WO2019059412A1 - Agent de lutte prolongée contre les ectoparasites pour un animal - Google Patents

Agent de lutte prolongée contre les ectoparasites pour un animal Download PDF

Info

Publication number
WO2019059412A1
WO2019059412A1 PCT/JP2018/036162 JP2018036162W WO2019059412A1 WO 2019059412 A1 WO2019059412 A1 WO 2019059412A1 JP 2018036162 W JP2018036162 W JP 2018036162W WO 2019059412 A1 WO2019059412 A1 WO 2019059412A1
Authority
WO
WIPO (PCT)
Prior art keywords
group
atom
spp
trifluoromethyl
phenyl
Prior art date
Application number
PCT/JP2018/036162
Other languages
English (en)
Inventor
Yoji Aoki
Shinichi Banba
Markus Berger
Lars Baerfacker
Original Assignee
Mitsui Chemicals Agro, Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to MX2020002982A priority Critical patent/MX2020002982A/es
Priority to UAA202002397A priority patent/UA125914C2/uk
Application filed by Mitsui Chemicals Agro, Inc. filed Critical Mitsui Chemicals Agro, Inc.
Priority to RU2020113549A priority patent/RU2770703C2/ru
Priority to AU2018335796A priority patent/AU2018335796A1/en
Priority to CN201880060639.5A priority patent/CN111132549B/zh
Priority to KR1020207011091A priority patent/KR102590088B1/ko
Priority to CN202210305455.9A priority patent/CN114591232A/zh
Priority to JP2020516756A priority patent/JP7277445B2/ja
Priority to BR112020005628-6A priority patent/BR112020005628A2/pt
Priority to CA3076539A priority patent/CA3076539A1/fr
Priority to US16/648,530 priority patent/US11696913B2/en
Priority to EP18792551.6A priority patent/EP3684181A1/fr
Publication of WO2019059412A1 publication Critical patent/WO2019059412A1/fr
Priority to IL273416A priority patent/IL273416B2/en
Priority to JP2023017159A priority patent/JP2023052979A/ja
Priority to US18/119,564 priority patent/US20230226037A1/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/78—Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D213/81—Amides; Imides
    • C07D213/82—Amides; Imides in position 3
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N43/00—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds
    • A01N43/34—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with one nitrogen atom as the only ring hetero atom
    • A01N43/40—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with one nitrogen atom as the only ring hetero atom six-membered rings
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N37/00—Biocides, pest repellants or attractants, or plant growth regulators containing organic compounds containing a carbon atom having three bonds to hetero atoms with at the most two bonds to halogen, e.g. carboxylic acids
    • A01N37/18—Biocides, pest repellants or attractants, or plant growth regulators containing organic compounds containing a carbon atom having three bonds to hetero atoms with at the most two bonds to halogen, e.g. carboxylic acids containing the group —CO—N<, e.g. carboxylic acid amides or imides; Thio analogues thereof
    • A01N37/22—Biocides, pest repellants or attractants, or plant growth regulators containing organic compounds containing a carbon atom having three bonds to hetero atoms with at the most two bonds to halogen, e.g. carboxylic acids containing the group —CO—N<, e.g. carboxylic acid amides or imides; Thio analogues thereof the nitrogen atom being directly attached to an aromatic ring system, e.g. anilides
    • A01N37/24—Biocides, pest repellants or attractants, or plant growth regulators containing organic compounds containing a carbon atom having three bonds to hetero atoms with at the most two bonds to halogen, e.g. carboxylic acids containing the group —CO—N<, e.g. carboxylic acid amides or imides; Thio analogues thereof the nitrogen atom being directly attached to an aromatic ring system, e.g. anilides containing at least one oxygen or sulfur atom being directly attached to the same aromatic ring system
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N41/00—Biocides, pest repellants or attractants, or plant growth regulators containing organic compounds containing a sulfur atom bound to a hetero atom
    • A01N41/02—Biocides, pest repellants or attractants, or plant growth regulators containing organic compounds containing a sulfur atom bound to a hetero atom containing a sulfur-to-oxygen double bond
    • A01N41/10—Sulfones; Sulfoxides
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N43/00—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds
    • A01N43/48—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with two nitrogen atoms as the only ring hetero atoms
    • A01N43/54—1,3-Diazines; Hydrogenated 1,3-diazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A61K31/166—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the carbon of a carboxamide group directly attached to the aromatic ring, e.g. procainamide, procarbazine, metoclopramide, labetalol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/455—Nicotinic acids, e.g. niacin; Derivatives thereof, e.g. esters, amides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/14—Ectoparasiticides, e.g. scabicides

Definitions

  • the present invention relates to the use of a specific carboxamide derivative in the prolonged control of ectoparasites on animals by systemic application of said compound to said animal and to preparations for said use.
  • the compound as disclosed herein exhibits an excellent activity with respect to protection from harmful organisms.
  • the compound has an excellent insecticidal activity, and have also found that the compound has a long-acting activity against ectoparasites upon systemic application to animals, and are therefore suitable for a prolonged control of ectoparasites on animals.
  • the present disclosure provides a prolonged ectoparasite-controlling agent for an animal, a preparation for systemic application for use in prolonged control of an ectoparasite on an animal, a method for prolonged control of an ectoparasite on an animal, use of the compound as disclosed herein for preparing a medicament for prolonged control of an ectoparasite on an animal, a horticultural or agricultural insecticide, a method of protecting a crop from a harmful organism, a composition including the compound as disclosed herein mixed with an inert carrier and an optional auxiliary agent, a mixture including the compound as disclosed herein combined with at least one other insecticide and/or fungicide, and a compound represeted by a specific chemical formula.
  • the present invention relates to the following aspects.
  • a prolonged ectoparasite-controlling agent for an animal represented by the following Formula ( 1 ) :
  • each of A 1 , A 2 and A 3 independently represents a nitrogen atom or a C-X 1 group, provided that at least one of A 1 or A 2 represents a C-X 1 group, and provided that when A 3 represents a nitrogen atom, A 1 represents C-X 1 and A 2 represents a nitrogen atom;
  • a 4 represents a C-X 1 group
  • R 1 represents a hydrogen atom or a C 1 -C 4 alkyl group
  • R 2 represents a trifluoromethyl group or a pentafluoroethyl group
  • X represents a halogen atom, a C 1 -C 4 alkyl group, a C 1 -C 4 haloalkyl group, a C 1 -C 4 alkoxyl group, a C 1 -C 4 haloalkoxyl, a C 1 -C 4 alkylthio group, a C 1 -C 4 haloalkylthio group, a C 1 - C 4 alkylsulfinyl group, a C 1 -C 4 haloalkylsulfinyl group, a C 1 -C 4 alkylsulfonyl group, a C 1 -C 4 haloalkylsulfonyl group, an aminosulfinyl group, an aminosulfonyl group, a sulfamoyl group, a nitro group or a cyano group;
  • each X) independently represents a hydrogen atom, a halogen atom, a C 1 -C 4 alkyl group, a C 1 -C 4 haloalkyl group, a C 1 -C 4 alkoxyl group, a C 1 -C 4 haloalkoxyl or a cyano group, provided that when X and X 1 are bonded to adjacent carbon atoms, X and X 1 together with the carbon atoms may form a five- or six-membered ring system which may be aromatic or non- aromatic, where the ring contains 0, 1 , 2 or 3 hetero atoms each independently selected from N, O and S as ring members;
  • each of X 2 , X 3 and X4 independently represents a hydrogen atom or a fluorine atom
  • X 5 represents a chlorine atom, a bromine atom or an iodine atom
  • Y represents a single bond, O, S, a sulfoxide group or a sulfonyl group.
  • each of A 1 and A 3 indepenently represents a C-X 1 group
  • a 2 represent a nitrogen atom or a C-X 1 group
  • a 4 represents a C-X 1 group
  • R 1 represents a hydrogen atom or a C 1 -C 4 alkyl group
  • R 2 represents a trifluoromethyl group
  • X represents halogen atom or a C 1 -C 4 haloalkyl group
  • X 1 represents a hydrogen atom
  • each of X 2 and X 4 represents a fluorine atom
  • X 3 represents a hydrogen atom
  • X 5 represents a bromine atom or an iodine atom
  • Y represents a single bond or a sulfonyl group.
  • a preparation for systemic application for use in prolonged control of an ectoparasite on an animal including the compound represented by Formula (1).
  • [11] A method for prolonged control of an ectoparasite on an animal, including systemically applying the compound represented by Formula (1).
  • a method of protecting a crop from a harmful organism including treating a crop or a soil for the crop with an effective amount of the compound represented by Formula (1).
  • a composition including the compound represented by Formula (1) mixed with an inert carrier, and optionally with an auxiliary agent.
  • R 1 represents a hydrogen atom or a C 1 -C 4 alkyl group
  • R 2 represents a trifluoromethyl group or a pentafluoroethyl group
  • X represents a fluorine atom, a difluoromethyl group or a trifluoromethyl group
  • X 5 represents a bromine atom or iodine atom
  • A represents a nitrogen atom or a C-H group
  • Y represents a single bond, O, S, a sulfoxide group or a sulfonyl group when A represents a nitrogen atom, and Y represents S, a sulfoxide group or a sulfonyl group when A represents a C-H group.
  • a prolonged ectoparasite-controlling agent for an animal a preparation for systemic application for use in prolonged control of an ectoparasite on an animal, a method for prolonged control of an ectoparasite on an animal, use of the compound as disclosed herein for preparing a medicament for prolonged control of an ectoparasite on an animal, a horticultural or agricultural insecticide, a method of protecting a crop from a harmful organism, a composition including the compound as disclosed herein mixed with an inert carrier and an optional auxiliary agent, a mixture including the compound as disclosed herein combined with at least one other insecticide and/or fungicide, and a compound represeted by a specific chemical formula, can be provided.
  • each of A 1 ; A 2 and A 3 independently represents a nitrogen atom or a C-X 1 group, provided that at least one of A 1 or A 2 represents a C-X 1 group, and provided that when A 3 represents a nitrogen atom, A 1 represents C-X 1 and A 2 represents a nitrogen atom;
  • A represents a C-X 1 group
  • R 1 represents a hydrogen atom or a C 1 -C 4 alkyl group
  • R 2 represents a trifluoromethyl group or a pentafluoroethyl group
  • X represents a halogen atom, a C 1 -C 4 alkyl group, a C 1 -C 4 haloalkyl group, a C 1 -C 4 alkoxyl group, a C 1 -C 4 haloalkoxyl, a C 1 -C 4 alkylthio group, a C 1 -C 4 haloalkylthio group, a C 1 - C 4 alkylsulfinyl group, a C 1 -C 4 haloalkylsulfinyl group, a C 1 -C 4 alkylsulfonyl group, a C 1 -C 4 haloalkylsulfonyl group, an aminosulfinyl group, an aminosulfonyl group, a sulfamoyl group, a nitro group or a cyano group;
  • each X 1 independently represents a hydrogen atom, a halogen atom, a C 1 -C 4 alkyl group, a C 1 -C 4 haloalkyl group, a C 1 -C 4 alkoxyl group, a C 1 -C 4 haloalkoxyl or a cyano group, provided that when X and X 1 are bonded to adjacent carbon atoms, X andX 1 together with the carbon atoms may form a five- or six-membered ring system which may be aromatic or non- aromatic, where the ring contains 0, 1 , 2 or 3 hetero atoms each independently selected from N, O and S as ring members;
  • each of X 2 , X 3 and X4 independently represents a hydrogen atom or a fluorine atom
  • X 5 represents a chlorine atom, a bromine atom or an iodine atom
  • Y represents a single bond, O, S, a sulfoxide group or a sulfonyl group.
  • C 1 -C 4 alkyl group in the present invention represents, for example, a linear or branched alkyl group having from 1 to 4 carbon atoms such as methyl, ethyl, n- propyl, i-propyl, n-butyl, i-butyl, s-butyl, t-butyl.
  • halogen atom in the present invention represents a fluorine atom, a chlorine atom, a bromine atom, or an iodine atom.
  • C 1 -C 4 haloalkyl group in the present invention represents, for example, a linear or branched alkyl group having from 1 to 4 carbon atoms substituted with one or more halogen atoms which may be the same as or different from each other, such as trifluoromethyl, pentafluoroethyl, heptafluoro-n-propyl, heptafluoro-i-propyl, 2,2-difluoroethyl, 2,2- dichloroethyl, 2,2,2-trifluoroethyl, 2-fluoroethyl, 2-chloroethyl, 2-bromoethyl, 2-iodoethyl, 2,2,2-trichloroethyl, 2,2,2-tribromoethyl, l,3-difluoro-2-propyl, l,3-dichloro-2-propyl, 1- chloro-3-fluoro
  • C 1 -C 4 alkoxy group in the present invention represents, for example, a linear or branched alkoxy group having from 1 to 4 carbon atoms, such as methoxy, ethoxy, n- propoxy, i-propoxy, n-butoxy, i-butoxy, s-butoxy or t-butoxy.
  • C 1 -C 4 haloalkoxy group in the present invention represents, for example, a linear or branched alkoxy group having from 1 to 4 carbon atoms substituted with one or more halogen atoms which may be the same as or different from each other, such as difluoromethoxy, trifluoromethoxy, pentafluoroethoxy, heptafluoro-n-propoxy, heptafluoro-i- propoxy, 2,2-difluoroethoxy, 2,2-dichloroethoxy, 2,2,2-trifluoroethoxy, 2-fluoroethoxy, 2- chloroethoxy, 2-bromoethoxy, 2-iodoethoxy, 2,2,2-trichloroethoxy, 2,2,2-tribromoethoxy, 1 ,3- difluoro-2-propoxy, l,3-dichloro-2-propoxy, l-chloro-3-fluoro-2-propoxy
  • C 1 -C 4 alkylthio group in the present invention represents, for example, a linear or branched alkylthio group having from 1 to 4 carbon atoms, such as methylthio, ethylthio, n-propylthio, i-propylthio, n-butylthio, i-butylthio, s-butylthio, or t-butylthio.
  • C 1 -C 4 haloalkylthio group in the present invention represents, for example, a linear or branched alkylthio group having from 1 to 4 carbon atom ssubstituted with one or more halogen atoms which may be the same as or different from each other, such as difluoromethylthio, trifluoromethylthio, pentafluoroethylthio, heptafluoro-n-propylthio, heptafluoro-i-propylthio, 2,2-difluoroethylthio, 2,2-dichloroethylthio, 2,2,2-trifluoroethylthio, 2-fluoroethylthio, 2-chloroethylthio, 2-bromoethylthio, 2-iodoethylthio, 2,2,2- trichloroethylthio, 2,2,2-tribromoeth
  • C 1 -C 4 alkylsulfinyl group in the present invention represents, for example, a linear or branched alkylsulfinyl group having from 1 to 4 carbon atoms, such as
  • C 1 -C 4 haloalkylsulfinyl group in the present invention represents, for example, a linear or branched alkylsulfinyl group having from 1 to 4 carbon atom ssubstituted with one or more halogen atoms which may be the same as or different from each other, such as difluoromethylsulfinyl, trifluoromethylsulfinyl, pentafluoroethylsulfinyl, heptafluoro-n- propylsulfinyl, heptafluoro-i-propylsulfinyl, 2,2-difluoroethylsulfinyl, 2,2- dichloroethylsulfinyl, 2,2,2-trifluoroethylsulfinyl, 2-fluoroethylsulfinyl, 2-chloroethylsulfinyl,
  • C 1 -C 4 alkylsulfonyl group in the present invention represents, for example, a linear or branched alkylsulfonyl group having from 1 to 4 carbon atoms, such as
  • C 1 -C 4 haloalkylsulfonyl group in the present invention represents, for example, a linear or branched alkylsulfonyl group having from 1 to 4 carbon atom ssubstituted with one or more halogen atoms which may be the same as or different from each other, such as difiuoromethylsulfonyl, trifluoromethylsulfonyl, pentafluoroethylsulfonyl, heptafluoro-n- propylsulfonyl, heptafluoro-i-propylsulfonyl, 2,2-difluoroethylsulfonyl, 2,2- dichloroethylsulfonyl, 2,2,2-trifluoroethylsulfonyl, 2-fluoroethylsulfonyl, 2- chloroethylsulfony
  • the C 1 -C 4 haloalkylsulfonyl group is a C 1 -C 4 fluoroalkylsulfonyl group, in particular a C 1 -C 4 perfluoroalkylsulfonyl group.
  • the compound represented by Formula (1) according to the present invention may include one or plural chiral carbon atoms or chiral centers in its structural formulae, and thus two or more optical isomers (enantiomers or diastereomers) may exist.
  • the scope of the present invention includes each of the optical isomers and mixtures thereof at any proportions.
  • X represents a fluorine atom or a trifluoromethyl group.
  • R 1 represents a hydrogen atom or a methyl group.
  • X 1 represents a hydrogen atom or a fluorine atom.
  • the compound represented by Formula (1) is a compound in which each of A 1 and A 3 indepenently represents a C-X 1 group, A 2 represent a nitrogen atom or a C- X 1 group, A represents a C-X 1 group, R 1 represents a hydrogen atom or a C 1 -C 4 alkyl group, R 2 represents a trifluoromethyl group: X represents halogen atom or a C 1 -C 4 haloalkyl group, X 1 represents a hydrogen atom, each of X 2 and X4 represents a fluorine atom, X 3 represents a hydrogen atom, X 5 represents a bromine atom or an iodine atom, and Y represents a single bond or a sulfonyl group.
  • Examples of the compound represented by Formula (1) which can be used in the present invention include the compounds listed in Table 1.
  • the compounds listed in Table 1 is represented by the following Formula (Formula (1)) in which R 1 is CH 3 , R 2 is CF 3 , X 2 is F, X 3 is H, X 4 is F, X 5 is I, Y is single bond, and A 1 , A 2 , A 3 , A 4 and X are as indicated in Table 1.
  • the present disclosure also includes Tables 2 through 240 below.
  • Tables 2 through 240 lists multiple compounds that are within the scope of Formula (1), similar to Table 1. More specifically, each of Tables 2 through 240 lists the same combinations of A 1 , A 2 , A 3 , A 4 and X as the combinations listed in Table 1 , but the combination of R 1 , R 2 , X 2 , X 3 , X 4 , X 5 and Y in each of Tables 2 through 240 differs from that in Table 1.
  • R 1 , R 2 , X 2 , X 3 , X 4 , X 5 and Y is such that " R 1 is CH 3 , R 2 is CF 3 , X 2 is F, X 3 is H, t is F, X 5 is I, and Y is single bond".
  • R l5 R 2 , X 2 , X 3 , X4, X 5 and Y in Table 2 is such that "R ⁇ is H, R 2 is CF 3 , X 2 is F, X 3 is H, X 4 is F, X 5 is I, and Y is single bond", as indicated below.
  • the first entry in Table 2 specifically discloses compound 2-fluoro-3-(4-fluorobenzamido)-N-(2-iodo-4-(perfluoropropan-2-yl)-6- (trifluoromethyl)phenyl)benzamide, which is a compound in which A 1 is CH, A 2 is CH, A 3 is CH, 4 is CH, X is F, R 1 is H, R 2 is CF 3 , X 2 is F, X 3 is H, X 4 is F, X 5 is I, and Y is single bond Note that the first entry in Table 1 indicates "A 1 is CH, A 2 is CH, A 3 is CH, A 4 is CH, X is F".
  • the compound specified in the second and subsequent entries in Table 2 can also be identified in the same manner, and the compounds listed in Tables 3 through 240 can also be identified in the same manner, taking into account the combination of R 15 R 2 , X 2 , X 3 , X 4 , X 5 and Y for each Table.
  • Preferred examples of compounds represented by Formula (1) that can be used in the present invention includes the compounds shown in the following Table 241.
  • Particularly preferred compounds represented by Formula (1) for use according to the present invention include the following compounds:
  • the compound represented by Formula (1) may be in the form of a solid, or in the form of a solvate, in particular a hydrate.
  • the compound in the form of a solvate, particularly hydrate, is also embraced by the invention.
  • Compounds represented by Formula (1) can be prepared using methods known in the art, see e.g. WO 2005/073165, WO 2010/018714, WO 2011/093415 as well as
  • the compound represented by Formula (1) is active against animal parasites, in particular ectoparasites or endoparasites.
  • animal parasites in particular ectoparasites or endoparasites.
  • the term endoparasite includes in particular helminths and protozoae, such as coccidia.
  • Ectoparasites are typically and preferably arthropods, in particular insects or acarids. Due to the toxicity of the compound represented by Formula (1) against animal parasites, the compound represented by Formula (1) may be used to control the animal parasites. In particular, the compound represented by Formula (1) has a prolonged effect with respect to control of ectoparasites, as demonstrated in the working examples described later.
  • the prolonged effect may provide, for example, at least 50% reduction (more preferably at least 60% reduction, still more preferably at least 70% reduction, further more preferably at least 80%, and particularly preferably at least 90% ) in the number of live pests compared to an untreated control for, for example, at least 16 days (more preferably at least 23 days, and still more preferably at least 30 days).
  • the test employed for determining the prolonged effect may be conducted by reference to Test Examples E and F described later.
  • the compound represented by Formula (1) has properties suitable for controlling parasites which occur in animal breeding and animal husbandry in livestock, breeding, zoo, laboratory, experimental and domestic animals, and the compound represented by Formula (1) has low toxicity against warm blooded animals. They are active against all or specific stages of development of the parasites.
  • a pr perfumed ectoparasite-controlling agent for an animal represented by Formula (1) is provided.
  • the compound represented by Formula (1) can suitably be used as a pr perfumed ectoparasite-controlling agent for an animal.
  • the prolonged ectoparasite-controlling agent may have a chemical structure in which: each of A 1 and A 3 indepenently represents a C-X 1 group; A 2 represent a nitrogen atom or a C-Xi group; A represents a C-X 1 group; R 1 represents a hydrogen atom or a C 1 -C 4 alkyl group; R 2 represents a trifluoromethyl group: X represents halogen atom or a C 1 -C 4 haloalkyl group; X 1 represents a hydrogen atom; each of X 2 and X4 represents a fluorine atom; X 3 represents a hydrogen atom; X 5 represents a bromine atom or an iodine atom; and Y represents a single bond or a sulfonyl group.
  • the prolonged ectoparasite-controlling agent may be systemically applied, and the application may be performed via at least one of an oral route, a parenteral route, or a dermal route
  • a preparation for systemic application for use in prolonged control of an ectoparasite on an animal including the compound represented by Formula (1).
  • Tthe preparation may be for at least one of oral use, parenteral use or dermal use.
  • the preparation may be a single-dose preparation.
  • preparation and the term “formulation” are used substantially interchangeably.
  • a method for prolonged control of an ectoparasite on an animal including systemically applying the compound represented by Formula (1).
  • use of the compound represented by Formula (1) for preparing a medicament for prolonged control of an ectoparasite on an animal including systemically applying the compound represented by Formula (1).
  • ectoparasite on an animal in which the medicament is applied systemically to the animal.
  • use of the compound represented by Formula (1) for prolonged control of an ectoparasite on an animal in which the medicament is applied systemically to the animal.
  • Agricultural livestock that may be treated with the compound represented by Formula (1) to control parasites include, for example, mammals, such as, sheep, goats, horses, donkeys, camels, buffaloes, rabbits, reindeers, fallow deers, and in particular cattle and pigs; or poultry, such as turkeys, ducks, geese, and in particular chickens; or fish or crustaceans, e.g. in aquaculture; or, as the case may be, insects such as bees.
  • mammals such as, sheep, goats, horses, donkeys, camels, buffaloes, rabbits, reindeers, fallow deers, and in particular cattle and pigs
  • poultry such as turkeys, ducks, geese, and in particular chickens
  • fish or crustaceans e.g. in aquaculture
  • insects such as bees.
  • domestic animals that may be treated with the compound represented by Formula (1) to control parasites include, for example, mammals, such as hamsters, guinea pigs, rats, mice, chinchillas, ferrets or in particular dogs, cats; cage birds; reptiles; amphibians or aquarium fish.
  • the compound represented by Formula (1) is administered to a mammal.
  • the compound represented by Formula (1) is administered to a bird, for example a cage bird or in particular poultry.
  • control means reduction of the incidence of the respective parasite in an animal infected with such parasites to innocuous levels. More specifically, “controlling”, as used herein, means efficacy in killing the respective parasite, inhibiting its growth, or inhibiting its proliferation.
  • arthropods that may be controlled using the compound represented by Formula (1) include, without any limitation:
  • Anoplurida for example, Haematopinus spp., Linognathus spp., Pediculus spp., Phtirus spp., Solenopotes spp.;
  • Nematocerina and Brachycerina for example Aedes spp., Anopheles spp., Atylotus spp., Braula spp., Calliphora spp., Chrysomyia spp., Chrysops spp., Culex spp., Culicoides spp., Eusimulium spp., Fannia spp., Gasterophilus spp., Glossina spp., Haematobia spp., Haematopota spp., Hippobosca spp., Hybomitra spp., Hydrotaea spp., Hypoderma spp., Lipoptena spp., Lucilia spp., Lutzomyia spp., Melophagus spp., Morellia spp., Musca spp.,
  • Siphonaptrida for example Ceratophyllus spp.; Ctenocephalides spp., Pulex spp., Tunga spp., Xenopsylla spp.;
  • exemplary arthropods that may be controlled using the compound represented by Formula (1) include the following acari, without any limitation: from the subclass of the Acari (Acarina) and the order of the Metastigmata, for example, from the family of argasidae like Argas spp., Omithodorus spp., Otobius spp., from the family of Ixodidae like Amblyomma spp., Dermacentor spp., Haemaphysalis spp., Hyalomma spp., Ixodes spp., Rhipicephalus (Boophilus) spp, Rhipicephalus spp.
  • acari without any limitation: from the subclass of the Acari (Acarina) and the order of the Metastigmata, for example, from the family of argasidae like Argas spp., Omithodorus spp., Otobius spp.
  • Exemplary parasitic protozoa that may be controlled using the compound represented by Formula (1) include, without any limitation:
  • Mastigophora such as:
  • Metamonada from the order Vaccinia spp. and Spironucleus spp.,
  • Trichomonadida from the order Trichomonadida, for example, Histomonas spp., Pentatrichomonas spp.,Tetratrichomonas spp., Trichomonas spp., and Tritrichomonas spp., and
  • Euglenozoa from the order Trypanosomatida, for example, Leishmania spp. and Trypanosoma spp.;
  • Sarcomastigophora such as Entamoebidae, for example, Entamoeba spp., Centramoebidae, for example, Acanthamoeba sp., and Euamoebidae, e.g. Hartmanella sp.;
  • Alveolata such as Apicomplexa (Sporozoa): e.g.
  • Eimeriida for example, Besnoitia spp., Cystoisospora spp., Eimeria spp., Hammondia spp., Isospora spp., Neospora spp., Sarcocystis spp., and Toxoplasma spp.,
  • Adeleida e.g. Hepatozoon spp., Klossiella spp.
  • Haemosporida e.g. Leucocytozoon spp., Plasmodium spp.
  • Piroplasmida e.g. Babesia spp., Ciliophora spp., Echinozoon spp., Theileria spp.
  • Vesibuliferida e.g. Balantidium spp., and Buxtonella spp.
  • Microspora such as Encephalitozoon spp., Enterocytozoon spp., Globidium spp., Nosema spp., and furthermore, e.g. Myxozoa spp.
  • Helminths pathogenic for humans or animals that may be controlled using the compound represented by Formula (1) include, for example, acanthocephala, nematodes, pentastoma and platyhelmintha (e.g. monogenea, cestodes and trematodes).
  • exemplary helminths that may be controlled using the compound represented by Formula (1) include, without any limitation:
  • Monogenea e.g.: Dactylogyrus spp., Gyrodactylus spp., Microbothrium spp.,
  • Cestodes including:
  • Diphyllobothrium spp. Diplogonoporus spp., Ichthyobothrium spp., Ligula spp., Schistocephalus spp., and Spirometra spp.
  • Cyclophyllida for example, Andyra spp., Anoplocephala spp., Avitellina spp., Bertiella spp., Cittotaenia spp., Davainea spp., Diorchis spp., Diplopylidium spp., Dipylidium spp., Echinococcus spp., Echinocotyle spp., Echinolepis spp., Hydatigera spp., Hymenolepis spp., Joyeuxiella spp., Mesocestoides spp., Moniezia spp., Paranoplocephala spp., Raillietina spp., Stilesia spp., Taenia spp., Thysaniezia spp., and Thysanosoma spp.;
  • Trematodes including:
  • Echinoparyphium spp. Echinostoma spp., Eurytrema spp., Fasciola spp., Fasciolides spp., Fasciolopsis spp., Fischoederius spp., Gastrothylacus spp., Gigantobilharzia spp., Gigantocotyle spp., Heterophyes spp., Hypoderaeum spp., Leucochloridium spp., Metagonimus spp., Metorchis spp., Nanophyetus spp., Notocotylus spp., Opisthorchis spp., Omithobilharzia spp., Paragonimus spp., Paramphistomum spp., Plagiorchis spp., Posthodiplostomum spp., Prosthogonimus
  • Nematodes including:
  • Trichinellida for example, Capillaria spp., Eucoleus spp., Paracapillaria spp., Trichinella spp., Trichomosoides spp., Trichuris spp.,
  • Parastrongyloides spp. Strongyloides spp., from the order of the Rhabditina, for example, Aelurostrongylus spp.,
  • Cylindropharynx spp. Cystocaulus spp., Dictyocaulus spp., Elaphostrongylus spp., Filaroides spp., Globocephalus spp., Graphidium spp., Gyalocephalus spp., Haemonchus spp.,
  • Parelaphostrongylus spp. Pneumocaulus spp., Pneumostrongylus spp., Poteriostomum spp., Protostrongylus spp., Spicocaulus spp., Stephanurus spp., Strongylus spp., Syngamus spp., Teladorsagia spp., Trichonema spp., Trichostrongylus spp., Triodontophorus spp.,
  • Spirurida for example, Acanthocheilonema spp., Anisakis spp., Ascaridia spp.; Ascaris spp., Ascarops spp., Aspiculuris spp., Baylisascaris spp., Brugia spp., Cercopithifilaria spp., Crassicauda spp., Dipetalonema spp., Dirofilaria spp., Dracunculus spp.; Draschia spp., Enterobius spp., Filaria spp., Gnathostoma spp., Gongylonema spp., Habronema spp., Heterakis spp.; Litomosoides spp., Loa spp., Onchocerca spp., Oxyuris spp., Parabronema spp., Parafilaria spp., Para
  • Acantocephala including:
  • Pentastoma including:
  • the administration of the compound represented by Formula (1) is carried out by methods generally known in the art, such as enterally, parenterally, dermally or nasally, in the form of suitable preparations. Administration can be carried out prophylactically, methaphylactically or therapeutically. Administration may be performed systemically.
  • a compound represented by Formula (1) for use as a medicament is provided.
  • a compound represented by Formula (1) for use as an anti-endoparasitical agent is provided.
  • a compound represented by Formula (1) for use as a anthelmintic agent more particularly for use as a nematicidal agent, a platyhelminthicidal agent, an acanthocephalicidal agent, or a pentastomicidal agent, is provided.
  • a compound represented by Formula (1) for use as an antiprotozoal agent is provided.
  • a compound represented by Formula (1) for use as an anti-ectoparasitical agent particularly an arthropodicidal agent, more particularly an insecticidal agent or acaricidal agent, is provided.
  • a veterinary formulation which includes an effective amount of at least one compound represented by Formula (1) and at least one of a pharmaceutically acceptable excipient (e.g. a solid or liquid diluent), a pharmaceutically acceptable auxiliary (e.g. a surfactant).
  • a veterinary formulation including an effective amount of at least one compound represented by Formula (1) and a pharmaceutically acceptable excipient and/or pharmaceutically acceptable auxiliary which is normally used in veterinary formulations is provided.
  • a method for preparing a veterinary formulation as described herein including a step of mixing at least one compound represented by Formula (1) with at least one of a pharmaceutically acceptable excipient or a pharmaceutically acceptable auxiliary.
  • the at least one of a pharmaceutically acceptable excipient or a pharmaceutically acceptable auxiliary may be selected from those normally used in veterinary formulations.
  • a veterinary formulation including a compound represented by Formula (1), which works as at least one of an ectoparasiticidal formulation or an endoparasiticidal formulation, is provided.
  • the veterinary formulation may work as at least one selected from the group of anthelmintic, antiprotozoal, and arthropodicidal formulations, and more specifically at least one selected from the group of nematicidal, platyhelminthicidal, acanthocephalicidal, pentastomicidal, insecticidal, and acaricidal formulations, depending on embodiments as well as their methods for preparation.
  • a method for treatment of a parasitic infection in particular an infection by a parasite selected from the group of ectoparasites and endoparasites, is provided which includes applying an effective amount of a compound represented by Formula (1) to an animal, in particular a non-human animal, in need thereof.
  • a method for treatment of a parasitic infection in particular an infection by a parasite selected from the group of ectoparasites and endoparasites, is provided which includes applying the veterinary formulation as defined herein to an animal, in particular a non-human animal, in need thereof.
  • a compound represented by Formula (1) in the treatment of a parasitic infection, in particular an infection by a parasite selected from the group of ectoparasites and endoparasites, in an animal, in particular a non-human animal is provided.
  • treatment encompasses prophylactic treatment, metaphylactic treatment as well as therapeutical treatment.
  • the present invention provides a pharmaceutical combination ("combination” sometimes also referred to as “mixture”), in particular a veterinary combination, which comprises:
  • one or more further active ingredients in particular one or more endo- and/or ectoparasiticides.
  • a "fixed combination” in the present invention is used as known to persons skilled in the art.
  • the fixed composition is, for example, a combination wherein one or more compounds represented by Formula (1) of the present invention, and one or more further active ingredients are present together in one unit dosage or in one single entity.
  • One example of a "fixed combination” is a pharmaceutical composition wherein a compound represented by Formula (1) and a further active ingredient are present in admixture for simultaneous administration, such as in a formulation.
  • Another example of a "fixed combination” is a pharmaceutical combination wherein a compound represented by Formula (1) and a further active ingredient are present in one unit without being in admixture.
  • a non-fixed combination or "kit-of-parts" in the present invention is used as known to persons skilled in the art.
  • the non-fixed combination is, for example, a combination wherein one or more compounds represented by Formula (1) and one or more further active ingredients are present in more than one unit.
  • One example of a non-fixed combination or kit-of-parts is a combination wherein a compound represented by Formula (1) and a further active ingredient are present separately.
  • the components of the non-fixed combination or kit-of-parts may be administered separately, sequentially, simultaneously, concurrently or chronologically staggered.
  • the compound represented by Formula (1) may be administered as the sole
  • the present invention also covers such pharmaceutical combinations.
  • the compound represented by Formula (1) may be combined with known ectoparasiticides and/or endoparasiticides.
  • insecticides examples include the following chemicals, without limitation:
  • Acetylcholinesterase (AChE) inhibitors such as carbamates, for example alanycarb, aldicarb, bendiocarb, benfuracarb, butocarboxim, butoxycarboxim, carbaryl, carbofuran, carbosulfan, ethiofencarb, fenobucarb, formetanate, furathiocarb, isoprocarb, methiocarb, methomyl, metolcarb, oxamyl, pirimicarb, propoxur, thiodicarb, thiofanox, triazamate, trimethacarb, XMC and xylylcarb; or organophosphates, for example acephate, azamethiphos, azinphos-ethyl, azinphos-methyl, cadusafos, chlorethoxyfos, chlorfenvinphos, chlormephos, chlorpyrifos-methyl,
  • GABA-gated chloride channel blockers such as cyclodiene-organochlorines, for example chlordane and endosulfan or phenylpyrazoles (fiproles), for example ethiprole and fipronil.
  • Sodium channel modulators such as pyrethroids, e.g. acrinathrin, allethrin, d-cis- trans allethrin, d-trans allethrin, bifenthrin, bioallethrin, bioallethrin s-cyclopentenyl isomer, bioresmethrin, cycloprothrin, cyfluthrin, beta-cyfluthrin, cyhalothrin, lambda-cyhalothrin, gamma-cyhalothrin, cypermethrin, alpha-cypermethrin, beta-cypermethrin, theta-cypermethrin, zeta-cypermethrin, cyphenothrin [(lR)-trans-isomer], deltamethrin, empenthrin [(EZ)-(IR)- isomer], e
  • Nicotinic acetylcholine receptor (nAChR) competitive modulators such as neonicotinoids, e.g. acetamiprid, clothianidin, dinotefuran, imidacloprid, nitenpyram, thiacloprid and thiamethoxam or nicotine or sulfoxaflor or flupyradifurone.
  • neonicotinoids e.g. acetamiprid, clothianidin, dinotefuran, imidacloprid, nitenpyram, thiacloprid and thiamethoxam or nicotine or sulfoxaflor or flupyradifurone.
  • Nicotinic acetylcholine receptor (nAChR) allosteric modulators such as spinosyns, e.g. spinetoram and spinosad.
  • Glutamate-gated chloride channel (GluCl) allosteric modulators such as
  • avermectins/milbemycins for example abamectin, emamectin benzoate, lepimectin and milbemectin.
  • Juvenile hormone mimics such as juvenile hormone analogues, e.g. hydroprene, kinoprene and methoprene or fenoxycarb or pyriproxyfen.
  • Mite growth inhibitors such as, for example clofentezine, hexythiazox and diflovidazin or etoxazole.
  • Inhibitors of mitochondrial ATP synthase such as, ATP disruptors such as diafenthiuron or organotin compounds, for example azocyclotin, cyhexatin and fenbutatin oxide or propargite or tetradifon.
  • Nicotinic acetylcholine receptor channel blockers such as bensultap, cartap hydrochloride, thiocylam, and thiosultap-sodium.
  • Inhibitors of chitin biosynthesis, type 0, such as bistrifluron, chlorfluazuron, diflubenzuron, flucycloxuron, flufenoxuron, hexaflumuron, lufenuron, novaluron, noviflumuron, teflubenzuron and triflumuron.
  • Inhibitors of chitin biosynthesis type 1, for example buprofezin.
  • Moulting disruptor in particular for Diptera, i.e. dipterans, such as cyromazine.
  • Ecdysone receptor agonists such as chromafenozide, halofenozide,
  • Octopamine receptor agonists such as amitraz.
  • Mitochondrial complex III electron transport inhibitors such as hydramethylnone or acequinocyl or fluacrypyrim.
  • Mitochondrial complex I electron transport inhibitors such as, for example from the group of the METI acaricides, e.g. fenazaquin, fenpyroximate, pyrimidifen, pyridaben, tebufenpyrad and tolfenpyrad or rotenone (Denis).
  • METI acaricides e.g. fenazaquin, fenpyroximate, pyrimidifen, pyridaben, tebufenpyrad and tolfenpyrad or rotenone (Denis).
  • Voltage-dependent sodium channel blockers such as, for example indoxacarb or metaflumizone.
  • Inhibitors of acetyl Co A carboxylase such as tetronic and tetramic acid derivatives, e.g. spirodiclofen, spiromesifen and spirotetramat.
  • Mitochondrial complex II electron transport inhibitors such as beta-ketonitrile derivatives, e.g. cyenopyrafen and cyflumetofen and carboxanilides, such as pyflubumide.
  • Ryanodine receptor modulators such as diamides, e.g. chlorantraniliprole, cyantraniliprole and flubendiamide.
  • Further examples include: further active ingredients such as Afidopyropen, Afoxolaner, Azadirachtin, Benclothiaz, Benzoximate, Bifenazate, Broflanilide, Bromopropylate,
  • Fluazaindolizine Fluensulfone, Flufenerim, Flufenoxystrobin, Flufiprole, Fluhexafon, Fluopyram, Fluralaner, Fluxametamide, Fufenozide, Guadipyr, Heptafluthrin, Imidaclothiz, Iprodione, kappa- Bifenthrin, kappa-Tefluthrin, Lotilaner, Meperfluthrin, Paichongding, Pyridalyl, Pyrifluquinazon, Pyriminostrobin, Spirobudiclofen, Tetramethylfluthrin, Tetraniliprole, Tetrachlorantraniliprole, Tioxazafen, Thiofluoximate, Triflumezopyrim and iodomethane; furthermore preparations based on Bacillus firmus (1-1582, BioNeem, Votivo), and also the following compounds: l- ⁇ 2-
  • active ingredients with unknown or non-specific mode of action e.g., fentrifanil, fenoxacrim, cycloprene, chlorobenzilate, chlordimeform, flubenzimine, dicyclanil, amidoflumet, quiiiomethionate, triarathene, clothiazoben, tetrasul, potassium oleate, petroleum, metoxadiazone, gossyplure, flutenzin, bromopropylate, cryolite;
  • active ingredients with unknown or non-specific mode of action e.g., fentrifanil, fenoxacrim, cycloprene, chlorobenzilate, chlordimeform, flubenzimine, dicyclanil, amidoflumet, quiiiomethionate, triarathene, clothiazoben, tetrasul, potassium oleate, petroleum, metoxadiazone, gossyplure, flutenzin, bromopropylate,
  • active ingredients from other classes e.g. butacarb, dimetilan, cloethocarb, phosphocarb, pirimiphos (-ethyl), parathion (-ethyl), methacrifos, isopropyl o-salicylate, trichlorfon, sulprofos, propaphos, sebufos, pyridathion, prothoate, dichlofenthion, demeton-S-methylsulphone, isazofos, cyanofenphos, dialifos, carbophenothion, autathiofos, aromfenvinfos (-methyl), azinphos (-ethyl), chlorpyrifos (-ethyl), fosmethilan, iodofenphos, dioxabenzofos, formothion, fonofos, flupyrazofos, fensulfothion
  • organochlorines e.g. camphechlor, lindane, heptachlor; or phenylpyrazoles, e.g.
  • acetoprole pyrafluprole, pyriprole, vaniliprole, sisapronil; or isoxazolines, e.g. sarolaner, afoxolaner, lotilaner, fluralaner;
  • pyrethroids e.g. (cis-, trans-), metofluthrin, profluthrin, flufenprox, flubrocythrinate, fubfenprox, fenfluthrin, protrifenbute, pyresmethrin, RU15525, terallethrin, cis-resmethrin, heptafluthrin, bioethanomethrin, biopermethrin, fenpyrithrin, cis-cypermethrin, cis-permethrin, clocythrin, cyhalothrin (lambda-), chlovaporthrin, or halogenated carbonhydrogen compounds (HCHs);
  • neonicotinoids e.g. nithiazine
  • macrocyclic lactones e.g. nemadectin, ivermectin, latidectin, moxidectin, selamectin, eprinomectin, doramectin, emamectin benzoate; milbemycin oxime;
  • dinitrophenols e.g. dinocap, dinobuton, binapacryl
  • benzoylureas e.g. fluazuron, penfluron
  • amidine derivatives e.g. chlormebuform, cymiazole, demiditraz.
  • bee hive varroa acaricides for example organic acids, e.g. formic acid, oxalic acid.
  • Preferred insecticides and acaricides for use in animal health include, without limitation: effectors at arthropod ligand gated chloride channels, such as chlordane, heptachlor, endoculfan, Dieldrin, bromocyclen, toxaphene, lindane, fipronil, pyriprole, sisapronil, afoxolaner, fluralaner, sarolaner, lotilaner, fluxametamide, broflanilide, averaiectin, doramectin, eprinomectin, ivermectin, milbemycin, moxidectin, and selamectin;
  • arthropod ligand gated chloride channels such as chlordane, heptachlor, endoculfan, Dieldrin, bromocyclen, toxaphene, lindane, fipronil, pyriprole, sisapronil, afoxo
  • arthropod octopaminergic receptors such as amitraz, BTS27271, cymiazole, and demiditraz;
  • arthropod voltage-gated sodium channels such as DDT, methoxychlor, metafiumizone, indoxacarb, cinerin I, cinerin II, jasmolin I, jasmolin II, pyrethrin I, pyrethrin II, allethrin, alphacypermethrin, bioallethrin, betacyfluthrin, cyfluthrin, cyhalothrin, cypermethrin, deltamethrin, etofenprox, fenvalerate, flucythrinate, flumethrin, halfenprox, permethrin, phenothrin, resmethrin, tau-fluvalinate, and tetramethrin;
  • acetylcholine receptors such as bromoprypylate, bendiocarb, carbaryl, methomyl, promacyl, propoxur, azamethiphos, chlorfenvinphos, chlorpyrifos, coumaphos, cythioate, diazinon, diclorvos, dicrotophos, dimethoate, ethion, famphur, fenitrothion, fenthion, heptenophos, malathion, naled, phosmet, phoxim, phtalofos, propetamphos, warmthphos, tetrachlorvinphos, trichlorfon, imidacloprid, nitenpyram, dinotefuran, spinosad, and spinetoram; and
  • effectors on arthropod development processes such as cyromazine, dicyclanil, diflubenzuron, fluazuron, lufenuron, triflumuron, fenoxycarb, hydroprene, methoprene, pyriproxyfen, fenoxycarb, hydroprene, S-methoprene, and pyriproxyfen.
  • Exemplary active ingredients from the group of endoparasiticides, as mixing partners, include, without limitation, anthelmintically active compounds and antiprotozoal active compounds.
  • Anthelmintically active compounds include, without limitation, the following nematicidally, trematicidally and/or cestocidally active compounds:
  • eprinomectin from the class of macrocyclic lactones, for example, eprinomectin, abamectin, nemadectin, moxidectin, doramectin, selamectin, lepimectin, latidectin, milbemectin, ivermectin, emamectin, and milbemycin;
  • benzimidazoles and probenzimidazoles for example, oxibendazole, mebendazole, triclabendazole, thiophanate, parbendazole, oxfendazole, netobimin, fenbendazole, febantel, thiabendazole, cyclobendazole, cambendazole, albendazole-sulphoxide, albendazole, and flubendazole;
  • depsipeptides preferably cyclic depsipetides, in particular 24- membered cyclic depsipeptides, for example, emodepside, and PF1022A;
  • tetrahydropyrimidines for example, morantel, pyrantel, and oxantel
  • class of imidazothiazoles for example, butamisole, levamisole, and tetramisole
  • aminophenylamidines for example, amidantel, deacylated amidantel (dAMD), and tribendimidine
  • paraherquamides for example, paraherquamide and derquantel
  • salicylanilides for example, tribromsalan, bromoxanide, brotianide, clioxanide, closantel, niclosamide, oxyclozanide, and rafoxanide
  • substituted phenols for example, nitroxynil, bithionol, disophenol, hexachlorophene, niclofolan, and meniclopholan;
  • organophosphates for example, trichlorfon, naphthalofos,
  • tetracyclines for example, tetracyclin, chlorotetracycline, doxycyclin, oxytetracyclin, and rolitetracyclin;
  • bunamidine from diverse other classes, for example, bunamidine, niridazole, resorantel, omphalotin, oltipraz, nitroscanate, nitroxynile, oxaniniquine, mirasan, miracil, lucanthone, hycanthone, hetolin, emetine, diethylcarbamazine, dichlorophen, diamfenetide, clonazepam, bephenium, amoscanate, and clorsulon.
  • Antiprotozoal active compounds include, without limitation, the following active compounds: from the class of triazines, for example, diclazuril, ponazuril, letrazuril, and toltrazuril; from the class of polylether ionophore, for example, monensin, salinomycin,
  • quinines for example, chloroquine
  • pyrimidines for example, pyrimethamine
  • sulfonamides for example, sulfaquinoxaline, trimethoprim, and sulfaclozin;
  • thiamines for example, amprolium
  • carbanilides for example, imidocarb
  • nitrofuranes for example, nifurtimox
  • quinazolinone alkaloids for example, halofuginon
  • Each named mixing partner may form a salt with a suitable base or acid if its functional group enable the formation of the salt.
  • the compound represented by Formula ( 1 ) may also be used in vector control.
  • a vector is an arthropod, in particular an insect or arachnid, capable of transmitting pathogens such as viruses, worms, single-cell organisms and bacteria from a reservoir (plant, animal, human, etc.) to a host.
  • the pathogens can be transmitted either mechanically (for example trachoma by non-stinging flies) to a host, or by injection (for example malaria parasites by mosquitoes) into a host.
  • Anopheles malaria, filariasis
  • Flies sleeping sickness (trypanosomiasis); cholera, other bacterial diseases;
  • Mites acariosis, epidemic typhus, rickettsialpox, tularaemia, Saint Louis encephalitis, tick-borne encephalitis (TBE), Crimean-Congo haemorrhagic fever, borreliosis;
  • Ticks borellioses such as Borrelia burgdorferi sensu lato., Borrelia duttoni, tick-borne encephalitis, Q fever (Coxiella burnetii), babesioses (Babesia canis canis), ehrlichiosis.
  • insects and arachnids such as mosquitoes, in particular of the genera Aedes, Anopheles, for example A. gambiae, A. arabiensis, A. funestus, A. dirus (malaria) and Culex, psychodids such as
  • Vector control is also possible if the compound represented by Formula (1) is resistance-breaking.
  • the compound represented by Formula (1) is suitable for use in the prevention of diseases and/or pathogens transmitted by vectors.
  • a further aspect of the present invention is the use of a compound represented by Formula (1) for vector control in the field of animal health.
  • Yet a further aspect of the present invention is the use of a compound represented by Formula (1) for vector control in the field of human health.
  • the compound represented by Formula ( 1 ) as an active ingredient can be used for controlling various pests which give damage to paddy rices, fruit trees, vegetables, other crops and flowers and ornamental plants in agricultural, horticultural or stored grain products, or sanitary pests.
  • Examples of organisms that can be controlled by the compound represented by Formula (1) also include vermin such as eelworm.
  • the compound represented by Formula (1) has a strong insecticidal effect against Lepidoptera such as cotton caterpillar
  • the compound represented by Formula (1) as an active ingredient have notable insecticidal effect against the above-described pests that damage various lowland crops, upland crops, fruit trees, vegetables, other crops and horticultural products.
  • the insecticidal effect of the invention can be obtained by treating the paddy field water, plant stems and leaves, or soil of the crops of lowland, upland, fruit trees, vegetables, other crops, and flowers and ornamental plants, during the seasons expected of the appearance of such pests, or before or at the point of pest appearance.
  • a horticultural or agricultural insecticide containing the compound represented by Formula (1) as an active ingredient is provided.
  • a method of protecting a crop from a harmful organism is provided, the method including treating a crop or a soil for the crop with an effective amount of the compound represented by Formula (1).
  • a composition including the compound represented by Formula (1) mixed with an inert carrier, and optionally with an auxiliary agent is provided.
  • a mixture including the compound represented by Formula (1) combined with at least one other insecticide and/or fungicide is provided.
  • the compound represented by Formula (1) is in general used in appropriate formulation forms according to the use, prepared by conventional methods for preparation of agricultural and horticultural chemicals. That is, the compound represented by Formula (1) may be used in suitable formulations, such as a suspension, an emulsion, a liquid formulation, a water-dispersible powder, a granule, a dust formulation, a tablet or the like, prepared by blending the compound with at least one of a suitable inert carrier or an auxiliary agent, if necessary, in an appropriate proportion, followed by dissolution, separation, suspension, mixing, impregnation, adsorption or adhesion of the ingredients.
  • suitable formulations such as a suspension, an emulsion, a liquid formulation, a water-dispersible powder, a granule, a dust formulation, a tablet or the like, prepared by blending the compound with at least one of a suitable inert carrier or an auxiliary agent, if necessary, in an appropriate proportion, followed by dissolution, separation, suspension, mixing, impre
  • the inert carrier that can be used in the invention may be a solid or a liquid, and examples thereof include, in particular, soybean powders, grain powders, wood powders, bark powders, coarse powders, tobacco powders, walnut shell powders, brans, cellulose powders, residues from plant extraction, synthetic polymers such as pulverized synthetic resins, clays (for example, kaolin, bentonite, acidic white clay), talc (for examples, talc, pyrophyllite, etc.), silica (for examples, diatomite, sand, mica, white carbon (hydrous silica powders, hydrous silica powders called synthetic high dispersity silicic acids, there are also products containing calcium silicate as main component)), activated carbon, sulfur powder, pumice,
  • calcined diatomaceous powders pulverized bricks, fly ash, sand, inorganic mineral powders such as calcium carbonate and calcium phosphate, chemical fertilizers such as ammonium sulfate, ammonium phosphate, ammonium nitrate, urea and ammonium chloride, and a compost, which are used singly or in mixture of two or more thereof.
  • Examples of materials that can be used as an inert carrier in the form of a liquid include those having the function as solvent, as well as those not having the function as solvent but still capable of dispersing the active ingredient compound under an aid of an auxiliary agent.
  • the inert carrier include: water, alcohols (e.g., methanol, ethanol, isopropanol, butanol, ethylene glycol, etc.), ketones (e.g., acetone, methyl ethyl ketone, methyl isobutyl ketone, diisobutylketone, cyclohexanone, etc.), ethers (e.g., diethyl ether, dioxane, cellosolve, diisopropyl ether, tetrahydrofuran, etc.), aliphatic hydrocarbons (e.g., kerosene, mineral oil, etc.), aromatic hydrocarbons (e.g., benzene, toluene
  • auxiliary agent examples include the following auxiliary agents, which are used singly or in combination of two or more of them depending on the purpose; however, it is also possible not to use any auxiliary agent.
  • surfactants For the purpose of emulsification, dispersion, solubilization and/or wetting of the active ingredient compound, surfactants may be used.
  • surfactants include polyoxyethylene alkyl ethers, polyoxyethylene alkyl aryl ethers, polyoxyethylene higher fatty acid esters, polyoxyethylene resin acid esters, polyoxyethylene sorbitan monolaurate, polyoxyethylene sorbitan monooleates, alkyl aryl sulfonate, naphthalene sulfonate, lignin sulfonate, and higher alcohol sulfonate esters.
  • auxiliary agents that may be used for the purpose of dispersion stabilization, adhesion and/or binding of the active ingredient compound include casein, gelatin, starch, methyl cellulose, carboxymethyl cellulose, gum Arabic, polyvinyl alcohol, pine root oil, corn oil, bentonite, xanthan gum, and lignin sulfonate salts.
  • auxiliary agents examples include wax, stearic acid salts, and phosphoric alkyl esters.
  • An auxiliary agent such as a naphthalene sulfonate condensation product or a condensed phosphate salt may be used as a suspending agent in suspensions.
  • An antifoaming agent such as silicone oils can be also used as an auxiliary agent.
  • the compound represented by Formula (1) is stable against light, heat, oxidation and the like, but if desired, more stable compositions may be obtained by adding a stabilizer.
  • the stabilizer include antioxidants, UV absorbents, phenol derivatives such as BHT (2, 6-di-t-butyl-4-methyl phenol), BHA (butylhydroxy anisole), bisphenol derivatives, and aryl amines such as phenyl-a-naphthyl amine, phenyl- -naphthyl amine, condensation product of phenetidine and acetone, and benzophenone compounds.
  • the effective amount of the compound represented by Formula (1) is typically 0.5 to 20% by weight in a dust formulation, 5 to 50% by weight in an emulsion, 10 to 90% by weight in a water-dispersible powder, 0.1 to 20% by weight in a granule, and 10 to 90% by weight in a flowable formulation.
  • the amount of carrier in the respective formulations is typically 60 to 99% by weight in a dust formulation, 40 to 95% by weight in an emulsion, 10 to 90% by weight in a water-dispersible powder, 80 to 99% by weight in a granule, and 10 to 90% by weight in a flowable formulation.
  • auxiliary agent such as those described above, is typically 0.1 to 20% by weight in a dust formulation, 1 to 20% by weight in an emulsion, 0.1 to 20% by weight in a water-dispersible powder, 0.1 to 20% by weight in a granule, and 0.1 to 20% by weight in a flowable formulation.
  • an amount of the compound represented by Formula (1) as an active ingredient that is effective for blight control may be applied, just as it is, or as an adequate dilution with water, or as a suspension, to the crops expected of the appearance of the corresponding pests or to the places where such occurrence is not preferable.
  • the amount of use depends on various factors such as the purpose, the pest to be controlled, the state of plant growth, trend of pest appearance, climate, environmental conditions, formulation, method of use, place of use, timing of use and the like. It is preferable to use the compound represented by Formula (1) as an active ingredient in the concentration of 0.0001 to 5000 ppm, and preferably 0.01 to 1000 ppm.
  • the dose of the compound represented by Formula (1) that can be used in approximately 10 a (acre) is generally in the range of 1 to 300 g of the active ingredient.
  • the compound represented by Formula (1) as an active ingredient may be used alone in control of various pests in agricultural, horticultural and stored grain products, which damage the rice plants, fruit trees, vegetables, other crops and flowers, or sanitary pests or eelworms. Further, in order to obtain superior control effect with respect to various pests which occur at the same time, the compound represented by Formula (1) may be used in combination with at least one other insecticide and/or fungicide.
  • examples of an insecticide, a miticide or a nematicide as a compound which can be combined with the compound represented by Formula (1) include a compound selected from a pyrethroidbased compound, an organo phosphorus-based compound, an oxime-carbamate- based compound, a carbamate-based compound, a neonicotinoid-based compound, a diacylhydrazinebased compound, a benzoyl urea-based compound, a juvenile hormone-based compound, a cyclodiene organic chlorinebased compound, a 2-dimethylaminopropane-l,3- dithiolbased compound, an amidine-based compound, a phenylpyrazole-based compound, an organo tin-based compound, a METI-based compound, a benzylate-based compound, an allylpyrrol-based compound, a dinitrophenolbased compound, an anthrany
  • Examples of a fungicide which can be combined with the compound represented by Formula (1) include a strovilurin-based compound, an anilinopyrimidine-based compound, an azole- based compound, an azole-based compound, a dithiocarbamate-based compound, a phenylcarbamate-based compound, an organic chlorine-based compound, a benzimidazole- based compound, a phenylamide-based compound, a sulfenic acid-based compound, a copper- based compound, an isoxazole-based compound, an organo phosphorus-based compound, a N- halogenothioalkyl-based compound, a carboxyanilide-based compound, a morpholine-based compound, an organo tin-based compound, and a cyanopyrrol-based compound.
  • a fumigating agent such as chloropicrin or a natural product compound, for example, nicotine may also be used in combination with the compound represented by Formula (1).
  • Examples of compounds that may be used in combination with the compound represented by Formula (1) further include compounds other than the above groups. Specific examples include the following compounds:
  • pyrethroid-based compounds and various isomers thereof such as acrinathrin, allethrin [(lR)-isomer], bifenthrin, bioallethrin, bioallethrin S-cyclopentenyl isomer, bioresmethrin, cycloprothrin, cyfluthrin, beta-cyfluthrin, cyhalothrin, gamma-cyhalothrin, lambda-cyhalothrin, cypermethrin, alpha-cypermethrin, beta-cypermethrin, thetacypermethrin, zeta-cypermethrin, cyphenothrin [(1 R)-trans isomer], deltamethrin, empenthrin [(EZ)-(IR)- isomer], esfenvalerate, ethofenprox, fenpropathrin
  • organo phosphorus-based compounds such as acephate, azamethiphos, azinphos- methyl, azinphos-ethyl, cadusafos, chlorethoxyfos, chlorfenvinphos, chlormephos, chlorpyrifos, chlorpyrifos-methyl, coumaphos, CYAP (cyanophos), demeton-S-methyl, diazinon, ECP (dichlofenthion), DDVP (dichlorvos), dicrotophos, dimethoate,
  • methamidophos DMTP (methidathion), mevinphos, monocrotophos, BRP (paled), onmethoate, oxydemeton-methyl, parathions, parathion-methyl, PAP (phenthoate), phorate, phosalone, phosmet, phosphamidon, phoxim, pirimiphos-methyl, profenofos, propetamphos, prothiofos, pyraclofos, pyridaphenthion, quinalphos, Sulfotep, tebupirimfos, temephos, terbufos, thiometon, triazophos, DEP (trichlorfon), vamidothion, Bayer 22/190 (chlorothion), bromfenvinfos, bromophos, bromophos-ethyl butathiofos, carbophenothion.
  • Chlorphoxim Chlorphoxim, sulprofos, diamidafos, CVMP (tetrachlorvinphos), propaphos, mesulfenfos, dioxabenzofos (salithion), etrimfos, oxydeprofos, formothion, fensulfothion, isazofos, imicyafos (AKD3088), isamidofos, thionazin, and fosthietan;
  • oxime-carbamate-based compounds such as phosphocarb, alanycarb, butocarboxim, butoxycarboxim, thiodicarb, and Thiofanox;
  • carbamate-based compounds such as aldicarb, bendiocarb, benfuracarb, NAC
  • neonicotinoid-based compounds such as acetamiprid, clothianidin, dinotefuran, imidacloprid, nitenpyram, thiacloprid, and thiamethoxam;
  • diacylhydrazine-based compounds such as chromafenozide, halofenozide, methoxyfenozide, and tebufenozide,
  • benzoyl urea-based compounds such as bistrifluron, chlortluazuron, ditlubenzuron, flucycloxuron, flufenoxuron, hexaflumuron, lufenuron, novaluron, noviflumuron,
  • juvenile hormone-based compounds such as fenoxycarb, hydroprene, kinoprene, methoprene, pyriproxyfen, methoprene, and hydroprene;
  • cyclodiene organic chlorine-based compounds such as chlordane, endosulfan, lindane (gamma-HCH), and dienochlor;
  • 2-dimethylaminopropane-l,3-dithiol-based compounds such as Cartap hydrochloride and thiocyclam;
  • amidine-based compounds such as amitraz
  • phenylpyrazole-based compounds such as ethiprole, fipronil, and acetoprole;
  • organo tin-based compounds such as azocyclotin, cyhexatin, and fenbutatin oxide
  • mitochondrial electron transport inhibitor (METI)-based compounds such as fenazaquin, fenpyroximate, pyridaben, pylimidifen, tebufenpyrad, or tolfenpyrad;
  • benzylate-based compounds such as bromopropylate
  • allylpyrrol-based compounds such as chlorfenapyl
  • dinitrophenol-based compounds such as dinitro-ortho-cresol (DNOC) or binapacryl
  • DNOC dinitro-ortho-cresol
  • anthranyl-diamide-based compounds such as chlorantraniliprole and cyantraniliprole
  • oxadiazine-based compounds such as indoxacarb
  • semicarbazone-based compounds such as metaflumizone
  • tetronic acid-based compounds such as spirodiclofen, spiromesifen, and
  • carbamoyltriazole-based compounds such as triazamate
  • tetrazine-based compounds such as diflovidazin
  • insecticides such as abamectin, emamectin benzoate, milbemectin, lepimectin, acequinocyl, azadirachtin, bensultap, Benzoximate, bifenazate, buprofezin, CCA-50439, chinomethionat, clofentezine, cryolite, cyromazine, dazomet, dichlorodiisopropyl ether (DCIP), dichloro-diphenyl-trichloroethane (DDT), diafenthiuron, D- D (1,3-Dichloropropene), dicofol, dicyclanil, dinobuton, dinocap, ENT 8184, etoxazole, flonicamid, fluacrypyrim, fiubendiamide, GY-81 (peroxocarbonate), hexythiazox,
  • pyrifluquinazon cyflumetofen, amidoflumet, IKA-2005, cyenopyrafen sulfoxaflor, pyrafluprole, pyriprole, tralopyril, flupyrazofos, diofenolan, chlorobenzilate, flufenzine, benzomate, flufenerim, Tripropyl isocyanurate (TPIC), albendazole, oxibendazole, fenbendazole, metam-sodium, 1,3-dichloropropene, flupyradifurone, afidopyropen, flometoquin, pyflubumide, fluensulfone, tetraniliprole, cyclaniliprole, fluxametamide, broflanilide, dicloromezotiaz, triflumezopyrim, fluazaindolizine, tioxazafen and fluhexafon;
  • anilinopyrimidine-based compounds such as mepanipyrim, pyrimethanil, and cyprodinil;
  • azole-based compounds such as triadimefon, bitertanol, triflumizole, metoconazole, propiconazole, penconazole, flusilazole, myclobutanil, cyproconazole, tebuconazole, hexaconazole, prochloraz, and simeconazole;
  • quinoxaline-based compounds such as quinomethionate
  • dithiocarbamate-based compounds such as maneb, zineb, mancozeb, polycarbamate, and propineb;
  • phenylcarbamate-based compound such as diethofencarb
  • organic chlorine-based compounds such as chlorothalonil and quintozene
  • benzimidazole-based compounds such as benomyl, thiophanate-methyl, and carbendazole;
  • phenylamide-based compounds such as metalaxyl, oxadixyl, ofurase, benalaxyl, furalaxyl, and cyprofuram;
  • sulfenic acid-based compounds such as dichlofluanid
  • copper-based compounds such as copper hydroxide and oxine-copper
  • isoxazole-based compounds such as hydroxyisoxazole
  • organo phosphorus-based compounds such as fosetyl-aluminium and tolclofos- methyl;
  • N-Halogenothioalkyl-based compounds such as captan, captafol, and folpet;
  • dicarboxyimide-based compounds such as procymidone, iprodione, and vinchlozolin; carboxyanilide-based compounds, such as flutolanil, meproniL furamepyr, thifluzamide, boscalid, and penthiopyrad;
  • morpholine-based compounds such as fenpropimorph and dimethomorph
  • organo tin-based compounds such as fenthin hydroxide and fenthin acetate
  • cyanopyrrol-based compounds such as fludioxonil and fenpiclonil
  • fungicides such as tricyclazole, pyroquilon, carpropamid, diclocymet, fenoxanil, fthalide, fluazinam, cymoxanil, triforine, pyrifenox, fenarimol, fenpropidin, pencycuron, ferimzone, cyazofamid, iprovalicarb, benthiavalicarb-isopropyl, iminoctadin-albesilate, cyflufenamid, kasugamycin, validamycin, streptomycin, oxolinic-acid, tebufloquin,
  • probenazole tiadinil, isotianil, tolprocarb, or isofetamid, fenpicoxamid, quinofumelin, pydiflumetofen, dipymetitrone, and pyraziflumid;
  • fumigating agents such as chloropicrin, ethylene dibromide ' (EDB), sulfuryl fluoride, acrylonitrile, bis(2-chloroethyl)ether, l-bromo-2-chloroethane, 3-bromo-l-chloroprop-l-ene, bromocyclen, carbon disulfide, tetrachloromethane, metham sodium, nemadectin, and aluminium phosphide;
  • EDB ethylene dibromide '
  • sulfuryl fluoride acrylonitrile
  • bis(2-chloroethyl)ether l-bromo-2-chloroethane
  • 3-bromo-l-chloroprop-l-ene bromocyclen
  • carbon disulfide tetrachloromethane
  • metham sodium nemadectin, and aluminium phosphide
  • propylene glycol fatty acid ester diatomite, and Bacillus thuringiensis; and, furthermore;
  • a mixed composition of the compound represented by Formula (1) and the other insecticide and/or fungicide may be used; alternatively, the compound represented by Formula (1) and the other insecticide/fungicide may be mixed and used at the time of applying.
  • the mixing ratio of the compound represented by Formula (1) to the other insecticide and/or fungicide is, although not particularly limited, from 0.01 : 100 to 100:0.01, or from 0.1 :100 to 100:0.1, or from 1 :100 to 100:1, or from 1 :10 to 10:1, or 1 : 1 (all in terms of weight) when expressed as the compound of the inventio other insecticide and/or fungicide.
  • any range obtained by replacing the upper limit or the lower limit of any of the above ranges by the upperlimit or the lower limit of another range is also
  • the compound represented by Formula (1) may be mixed with a plant protecting agent, such as a herbicide, a fertilizer, a soil reformer, a plant growth controlling agent or any other material which are expected to provide an additive effect or a synergistic effect, in order to form a multi-purpose composition having high efficacy.
  • a plant protecting agent such as a herbicide, a fertilizer, a soil reformer, a plant growth controlling agent or any other material which are expected to provide an additive effect or a synergistic effect, in order to form a multi-purpose composition having high efficacy.
  • Rt represents a hydrogen atom or a C 1 -C 4 alkyl group
  • R 2 represents a trifluoromethyl group or a pentafluoroethyl group
  • X represents a fluorine atom, a difluoromethyl group or a trifluoromethyl group
  • X 5 represents a bromine atom or iodine atom
  • A represents a nitrogen atom or a C-H group
  • Y represents a single bond, O, S, a sulfoxide group or a sulfonyl group when A represents a nitrogen atom, and Y represents S, a sulfoxide group or a sulfonyl group when A represents a C-H group.
  • the compound represented by Formula (2) is also useful as a prolonged ectoparasite- controlling agent, or as a horticultural or agricultural insecticide, or for protecting a crop from a harmful organism. Therefore, the compound represented by Formula (2) can similarly be used in the compositions, mixtures, formulations, preparations, methods, uses and the like in which the compound represented by Formula (1) is used.
  • the compound represented by Formula (2) can be prepared with reference to methods known in the art, see e.g. WO 2005/073165, WO 2010/018714, WO 2011/093415 as well as WO2010/013567 and WO 2010/018857. Exemplary synthesis methods will be detailed in Examples 1 to 9. [0153]
  • the compound represented by Formula (2) is preferably selected from the group consisting of
  • Example 1 Preparation of N-(2-fluoro-3-((2-iodo-4-(perfluoropropan-2-yl)-6- (trifluoromethyl)phenyl)carbamoyl)phenyl)-6-(trifluoromethyl)nicotinamide (Compound 67) [0156] Step 1-A: Preparation of 4-(perfluoropropan-2-yl)-2-(trifluoromethyl)aniline
  • Step 1 -B Preparation of 2-iodo-4-(perfluoropropan-2-yl)-6-(trifluoromethyl)aniline
  • Step 1-C Preparation of 2-fluoro-3-nitrobenzoyl chloride
  • Step 1-D Preparation of 2-fluoro-N-(2-iodo-4-(perfluoropropan-2-yl)-6- (trifluoromethyl)phenyl)-3-nitrobenzamide
  • Step 1-E Preparation of 3-amino-2-fluoro-N-(2-iodo-4-(perfluoropropan-2-yl)-6- (trifluoromethyl)phenyl)benzamide
  • Step 1 -F Preparation of 6-(trifluoromethyl)nicotinoyl chloride
  • 6- (trifluoromethyl)nicotinic acid 782 g, 4.09 mol
  • N,N-dimethylformamide 10.6 g
  • toluene 2340 g
  • thionylchloride 878 g, 7.38 mol
  • Step 1-G Preparation of N-(2-fluoro-3-((2-iodo-4-(perfluoropropan-2-yl)-6- (trifluoromethyl)phenyl)carbamoyl)phenyl)-6-(trifluoromethyl)nicotinamide (Compound 67)
  • Example 2 Preparation of N-(2-fluoro-3-((2-bromo-4-(perfluoropropan-2-yl)-6- (trifluoromethoxy)phenyl)carbamoyl)phenyl)-6-(trifluoromethyl)nicotinamide (Compound 99)
  • Step 2- A Preparation of 4-(perfluoropropan-2-yl)-6-(trifluoromethoxy)aniline According to the method of Step 1-A of Example 1, 4-(perfluoropropan-2-yl)-6- (trifluoromethoxy)aniline was prepared from 2-trifluoromethoxyaniline.
  • Step 2-B Preparation of 2-bromo-4-(perfluoropropan-2-yl)-6- (trifluoromethoxy)aniline
  • N-Bromosuccinimide (4.33 g, 24.3 mmol) was added portionwisely to a N,N- dimethylformamide (42 mL) solution of 4-(perfluoropropan-2-yl)-6-(trifluoromethoxy)aniline (7.0 g, 20.3 mmol), and the resulting mixture was stirred at room temperature overnight.
  • Step 2-C Preparation of 2-fluoro-N-(2-bromo-4-(perfluoropropan-2-yl)-6- (trifluoromethoxy)phenyl)-3-nitrobenzamide
  • the acid chloride thus obtained was added to the mixture of 2-bromo-4-(perfluoropropan-2- yl)-6-(trifluoromethoxy)aniline (5.5 g 13.1 mmol), l,3-dimethylimidazolidin-2-one (8.5 mL) and diisopropylethylamine (5.43 mL 31.1 mmol), the resulting mixture was heated to 110 °C and stirred for 3 hr at this temperature. After cooling the reaction mixture to room temperature, water and ethyl acetate were added and the resulting two layers were separated. The obtained organic layer was washed with IN HC1 aq., sat. NaHC0 3 aq. and sat.
  • Step 2-D Preparation of 3-amino-2-fluoro-N-(2-bromo-4-(perfluoropropan-2-yl)-6- (trifluoromethoxy)phenyl)benzamide
  • 2-Fluoro-N-(2-bromo-4-(perfluoropropan-2-yl)-6-(trifluoromethoxy)phenyl)-3- nitrobenzamide 4.9 g, 8.3 mmol
  • SnCl 2 (4.92 g, 25.9 mmol
  • Step 2-E Preparation of N-(2- fluoro -3-((2-bromo-4-(perfluoropropan-2-yl)-6- (trifluoromethoxy)phenyl)carbamoyl)phenyl)-6-(trifluoromethyl)nicotinamide (Compound 99)
  • Step 3-A Preparation of 2-iodo-4-(perfluoropropan-2-yl)-6-(trifluoromethoxy)aniline Sulfuric acid (0.87g, 0.1 eq) and iodine (6.29 g, 24.8 mmol) were added to a methanol (45 g) solution of 4-(perfluoropropan-2-yl)-6-(trifluoromethoxy)aniline (15.0 g, 43.5 mmol), and the resulting mixture was heated to 60 °C. 50.5 % ammonium peroxodisulfate aq. (6.43 g, 28.1 mmol) was added dropwisely to the solution at 60 °C.
  • Step 3-C Preparation of 2-fluoro-N-(2-iodo-4-(perfluoropropan-2-yl)-6- (trifluomethoxy)phenyl)-3-nitrobenzamide
  • Step 3-D Preparation of 3-amino-2-fluoro-N-(2-iodo-4-(perfluoropropan-2-yl)-6- (trfluoromethoxy)phenyl)benzamide
  • Step 3 -E Preparation of N-(2-fluoro-3 -((2-iodo-4-(perfluoropropan-2-yl)-6-
  • N-(2-fluoro-3-((2-iodo-4- (perfluoropropan-2-yl)-6-(trifluoromethoxy)phenyl)carbamoyl)phenyl)-6- (trifluoromethyl)nicotinamide was prepared from 6-(trifluoromethyl)nicotinic acid and 3- amino-2-fluoro-N-(2-iodo-4-(perfluoropropan-2-yl)-6-(trifluoromethoxy)phenyl)benzamide.
  • Example 4 Preparation of N-(2-fluoro-3-((2-iodo-4-(perfluoropropan-2-yl)-6- (trifluoromethoxy)phenyl)carbamoyl)phenyl)-N-methyl-6-(trifluoromethyl)nicotinamide (Compound 117)
  • Step 4- A Preparation of 2-fluoro-N-(2-iodo-4-(perfluoropropan-2-yl)-6- (trifluoromethoxy)phenyl)-3 -(methylamino)benzamide
  • Step 4-B Preparation of N-(2-fluoro-3 -((2-iodo-4-(perfluoropropan-2-yl)-6- (trifluoromethoxy)phenyl)carbamoyl)phenyl)-N-methyl-6-(trifluoromethyl)nicotinamide (Compound 117)
  • N-(2-fluoro-3-((2-iodo-4- (perfluoropropan-2-yl)-6-(trifluoromethoxy)phenyl)carbamoyl)phenyl)-N-methyl-6- (trifluoromethyl)nicotinamide was prepared from 6-(trifluoromethyl)nicotinic acid and 2- fluoro-N-(2-iodo-4-(perfluoropropan-2-yl)-6-(trifluoromethoxy)phenyl)-3- (methylamino)benzamide.
  • Step 5- A Preparation of 2-fluoro-N-(2-iodo-4-(perfluoropropan-2-yl)-6- (trifluoromethyl)phenyl)-3-(methylamino)benzamide
  • Step 5-B Preparation of N-(2-fluoro-3-((2-iodo-4-(perfluoropropan-2-yl)-6- (trifluoromethyl)phenyl)carbamoyl)phenyl)-N-methyl-6-(trifluoromethyl)nicotinamide (Compound 66)
  • N-(2-fluoro-3-((2-iodo-4- (perfluoropropan-2-yl)-6-(trifluoromethyl)phenyl)carbamoyl)phenyl)-N-methyl-6- (trifluoromethyl)nicotinamide was prepared from 6-(trifluoromethyl)nicotinic acid and 2- fluoro-N-(2-iodo-4-(perfluoropropan-2-yl)-6-(trifluoromethyl)phenyl)-3- (methylamino)benzamide .
  • Example 6 Preparation of 6-fluoro-N-(2-fluoro-3-((2-iodo-4-(perfluoropropan-2-yl)- 6-(trifluoromethyl)phenyl)carbamoyl)phenyl)nicotinamide (Compound 116)
  • 6-fluoronicotinic acid (21.45 g) was stirred with toluene (1 15 mL), and
  • Example 7 Preparation of 6-fluoro-N-(2-fluoro-3-((2-iodo-4-(perfluoropropan-2-yl)- 6-(trifluoromethyl)phenyl)carbamoyl)phenyl)-N-methylnicotinamide (Compound 115)
  • 6-fluoro-N-(2-fluoro-3-((2-iodo- 4-(perfluoropropan-2-yl)-6-(trifluoromethyl)phenyl)carbamoyl)phenyl)-N-methylnicotinamide was prepared from 2-fluoro-N-(2-iodo-4-(perfluoropropan-2-yl)-6-(trifluoromethyl)phenyl)-3- (methylamino)benzamide.
  • Example 8 Preparation of 2-fluoro-3 -(4-fluoro-N-methylbenzamido)-N-(2-iodo-4- (perfluoropropan-2-yl)-6-((trifluoromethyl)sulfonyl)phenyl)benzamide (Compound 70)
  • Step 8-A Preparation of 4-(perfluoropropan-2-yl)-2-((trifluoromethyl)thio)aniline
  • Step 1-A of Example 1 4-(perfluoropropan-2-yl)-2- ((trifluoromethyl)thio)aniline was prepared from 2-((trifluoromethyl)thio)aniline.
  • Step 8-B Preparation of 2-iodo-4-(perfluoropropan-2-yl)-6- ((trifluoromethyl)thio)aniline
  • peroxodisulfate aq. (119.09 g, 522 mmol) was added dropwisely to the solution at 60 °C. After stirring at 60 °C for 2 hr, iodine (21.4 g, 169 mmol) and ammonium peroxodisulfate (17.29 g, 361 mmol) were added and stirred at 60 °C for 1 hr. The resulting mixture was cooled to room temperature and an aqueous solution (450 mL) of Na 2 S0 3 (17.29 g) and water (593 mL) was added. The resulting mixture was extracted with n-heptane (4470 mL), and the obtained organic layer was washed with sat.
  • Step 8-C Preparation of 2-fluoro-N-(2-iodo-4-(perfluoropropan-2-yl)-6- ((trifluoromethyl)thio)phenyl)-3-nitrobenzamide
  • Step 8-D Preparation of 3-amino-2-fluoro-N-(2-iodo-4-(perfluoropropan-2-yl)-6- ((trifluoromethyl)thio)phenyl)benzamide
  • Step 8-E Preparation of 2-fluoro-3-(4-fluorobenzamido)-N-(2-iodo-4- (perfluoropropan-2-yl)-6-((trifluoromethyl)thio)phenyl)benzamide
  • Step 8-F Preparation of 2-fluoro-3-(4-fluoro-N-methylbenzamido)-N-(2-iodo-4- (perfluoropropan-2-yl)-6-((trifluoromethyl)sulfonyl)phenyl)benzamide (Compound 70)
  • Step 9-A Preparation of 2-fluoro-N-(2-iodo-4-(perfluoropropan-2-yl)-6- ((trifluoromethyl)thio)phenyl)-3-(methylamino)benzamide
  • Step 9-B Preparation of 2-fluoro-3-(4-fluoro-N-methylbenzamido)-N-(2-iodo-4- (perfluoropropan-2-yl)-6-((trifluoromethyl)thio)phenyl)benzamide
  • ((trifluoromethyl)thio)phenyl)benzamide was prepared from 2-fluoro-N-(2-iodo-4- (perfluoropropan-2-yl)-6-((trifluoromethyl)thio)phenyl)-3-(methylamino)benzamide.
  • Step 9-C Preparation of 2-fluoro-3-(4-fluoro-N-methylbenzamido)-N-(2-iodo-4- (perfluoropropan-2-yl)-6-((trifluoromethyl)sulfonyl)phenyl)benzamide (Compound 70)
  • test substance was dissolved and diluted in acetone p.a. to the desired concentration. The solution was then homogeneously applied to the inner wall and base of a glass tube by turning and rocking on an orbital shaker until complete evaporation of the solvent. For example, with a 900 ppm solution of test substance, an area-based dose of 5 ⁇ g/cm 2 was achieved.
  • a substance was judged to have good insecticidal activity against Ctenocephalides felis when at least 80% of the fleas were found dead or moribund at a dose of the substance of 5 ⁇ g/cm 2 . 100% insecticidal activity means that all the fleas were found dead or moribund. 0% insecticidal activity means that no fleas were found dead or moribund.
  • Test Example B In Vitro Contact Tests with Adult Hard Ticks
  • test substance was dissolved and diluted in acetone p.a. to the desired concentration.
  • the solution was then homogeneously applied to the inner wall and base of a glass vial by turning and rocking on an orbital shaker until complete evaporation of the solvent.
  • an area- based dose of 5 ⁇ g/cm 2 was achieved.
  • ticks were put in each coated test vial, which was then sealed with a perforated plastic lid and incubated in a horizontal position in the dark at room temperature and ambient humidity ⁇ Rhipicephalus sanguineus) or in a climate-controlled cabinet (Ixodes ricinus, Dermacentor variabilis, Amblyomma americanum [21°C, 85% rel. hum.]).
  • Acaricidal activity against the respective tick species was determined after 48 h. For this, ticks were collected to the base of the test vial by gentle knocking, and test vials were then incubated on a hotplate at 45-50°C for no longer than 5 min.. Ticks which remained motionless on the base of the test vial or moved uncoordinated without deliberately climbing up to avoid the heat were considered dead or moribund, respectively.
  • a substance was judged to have good acaricidal activity against the respective tick species when at least 80% of ticks were found dead or moribund at a dose of the substance of 5 ⁇ g/cm 2 .
  • An acaricidal activity of 100% means all ticks were dead or moribund.
  • An acaricidal activity of 0% means none of the ticks was found dead or moribund.
  • the following compounds from the preparation examples show an acaricidal activity of 90% at a dose of 5 ⁇ g/cm 2 against Ixodes ricinus: Compounds 24, 26, 9, 12, 16, 29, 35, 34, 80, 79, 67, 81, 82, 78, 74, 73, 72, 71, 64, 65, 68, 63, 84, 85, 86, 13, 89, 90, 91, 92, 93, 36, 95, 97, 101, 102, 104, 103, 106, 105, 108, 109, 110, 115, and 1 18.
  • test substance was dissolved and diluted in dimethyl sulphoxide to the desired concentration. 1 ⁇ of the test mixture was injected into the abdomen of each of 5 engorged adult female cattle ticks (Rhipicephalus (Boophilus) microplus). The ticks were transferred into petri dishes and maintained in a climate-controlled room [28°C, 85% rel. hum.].
  • Acaricidal activity against cattle ticks was assessed after 7 days by assessment of laid fertile eggs. Eggs which did not appear normal were stored in a climate-controlled cabinet [28°C, 85% rel h.] until larval hatch after 42 days. An acaricidal activity of 100% means that none of the ticks laid eggs or laid eggs were infertile; 0% means that the ticks laid eggs, and all the eggs were fertile.
  • test substance was dissolved in dimethyl sulphoxide and diluted with citrated cattle blood to the desired concentration.
  • Rats Topical Treatment In-vivo Test with American Dog Tick Nymph and Cat flea on Rats Type of study and overall study design: The method is a randomized non-blinded efficacy study in accordance with European animal welfare requirements. Rats (Rattus norvegicus) were randomized based on pre-treatment flea counts. The efficacy of treatment was determined by comparison of the flea and tick counts of different treatment groups versus the placebo-treated control group. The experimental unit was the individual study animal.
  • Method and route of administration The compound was applied in a suitable solvent and carrier (more specifically, added to the following mixture: 33.3 % by weight propylene carbonate, 67,7 % by weight N-methylpyrrolidone, 0.1 % by weight BHA, 0.05 % by weight BHT) considering the individual body weight as topical spot-on between the shoulder blades directly onto the skin.
  • a suitable solvent and carrier more specifically, added to the following mixture: 33.3 % by weight propylene carbonate, 67,7 % by weight N-methylpyrrolidone, 0.1 % by weight BHA, 0.05 % by weight BHT
  • Tick and Flea counting Rats were thoroughly examined and ticks and fleas were manually removed 48h ( ⁇ 4h) after tick infestation and 24h after flea infestation. Live fleas and live attached engorged ticks were counted. In non-evident cases, engorgement status was evaluated by squeezing the tick on a filter paper to find traces of blood as sign for
  • Table 248 Geometric mean percent reduction in live flea (Ctenocephalides felis) counts compared to untreated control rats
  • Type of study and overall study design The method is a randomized non-blinded efficacy study in accordance with European animal welfare requirements. Rats (Rattus norvegicus) were randomized based on pre-treatment flea counts. The efficacy of treatment was determined by comparison of the flea and tick counts of different treatment groups versus the placebo-treated control group. The experimental unit was the individual study animal. Method and route of administration: The compound was applied in a suitable solvent and carrier (more specifically, added to glycerol formal; in case of poorly soluble compounds, a solvent mixture with up to 25 % by volume of N-methyl pyrrolidone may be used.) considering the individual body weight as an intraperitoneal injection.
  • a suitable solvent and carrier more specifically, added to glycerol formal; in case of poorly soluble compounds, a solvent mixture with up to 25 % by volume of N-methyl pyrrolidone may be used.
  • Tick and Flea counting Rats were thoroughly examined and ticks and fleas were manually removed 48h ( ⁇ 4h) after tick infestation and 24h after flea infestation. Live fleas and live attached engorged ticks were counted. In non-evident cases, engorgement status was evaluated by squeezing the tick on a filter paper to find traces of blood as sign for
  • Table 249 Geometric mean percent reduction in live tick ⁇ Dermacentor variabilis) counts compared to untreated control rats
  • Test example G is a test example of
  • Cabbage leaves were immersed in a liquid containing the testing compound at a predetermined concentration for 30 seconds and air-dried.
  • the leaves were placed in a 7-cm polyethylene cup, and the second-stage larvae of common cutworm were left therein.
  • the cup was placed in a constant-temperature room at 25°C, and the survival rate was investigated after 6 days. The test was carried out with two groups of 5 larvae per group. As a result, Compound Nos.
  • Cabbage leaves were immersed in a liquid containing the testing compound at a predetermined concentration for 30 seconds and air-dried. They were placed in a 7-cm

Abstract

L'invention concerne un composé représenté par la formule (1) qui peut être utilisé en tant qu'agent de lutte prolongée contre les ectoparasites pour un animal. Une préparation pour application systémique destinée à être utilisée dans la lutte prolongée contre les ectoparasites chez un animal comprend le composé. Un procédé de lutte prolongée contre les ectoparasites sur un animal comprend l'application systémique du composé. Le composé peut être utilisé pour préparer un médicament pour une lutte prolongée contre les ectoparasites sur un animal. L'invention concerne également un insecticide horticole ou agricole contenant le composé, et un procédé de protection d'une culture contre un organisme nocif.
PCT/JP2018/036162 2017-09-20 2018-09-19 Agent de lutte prolongée contre les ectoparasites pour un animal WO2019059412A1 (fr)

Priority Applications (15)

Application Number Priority Date Filing Date Title
BR112020005628-6A BR112020005628A2 (pt) 2017-09-20 2018-09-19 agente de controle prolongado de ectoparasita para animais
JP2020516756A JP7277445B2 (ja) 2017-09-20 2018-09-19 動物用外部寄生虫長期防除剤
RU2020113549A RU2770703C2 (ru) 2017-09-20 2018-09-19 Агент, контролирующий эктопаразитов, длительного действия для животного
UAA202002397A UA125914C2 (uk) 2017-09-20 2018-09-19 Засіб для тварини для пролонгованої боротьби з ектопаразитами
CN201880060639.5A CN111132549B (zh) 2017-09-20 2018-09-19 动物用体外寄生虫长效防除剂
KR1020207011091A KR102590088B1 (ko) 2017-09-20 2018-09-19 동물용 외부 기생충 장기방제제
CA3076539A CA3076539A1 (fr) 2017-09-20 2018-09-19 Agent de lutte prolongee contre les ectoparasites pour un animal
MX2020002982A MX2020002982A (es) 2017-09-20 2018-09-19 Agente prolongado de control de ectoparasito para animales.
AU2018335796A AU2018335796A1 (en) 2017-09-20 2018-09-19 Prolonged ectoparasite-controlling agent for animal
CN202210305455.9A CN114591232A (zh) 2017-09-20 2018-09-19 动物用体外寄生虫长效防除剂
US16/648,530 US11696913B2 (en) 2017-09-20 2018-09-19 Prolonged ectoparasite-controlling agent for animal
EP18792551.6A EP3684181A1 (fr) 2017-09-20 2018-09-19 Agent de lutte prolongée contre les ectoparasites pour un animal
IL273416A IL273416B2 (en) 2017-09-20 2020-03-18 A long-term ectoparasitic agent for animals
JP2023017159A JP2023052979A (ja) 2017-09-20 2023-02-07 動物用外部寄生虫長期防除剤
US18/119,564 US20230226037A1 (en) 2017-09-20 2023-03-09 Prolonged ectoparasite-controlling agent for animal

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2017-179947 2017-09-20
JP2017179947 2017-09-20

Related Child Applications (2)

Application Number Title Priority Date Filing Date
US16/648,530 A-371-Of-International US11696913B2 (en) 2017-09-20 2018-09-19 Prolonged ectoparasite-controlling agent for animal
US18/119,564 Continuation US20230226037A1 (en) 2017-09-20 2023-03-09 Prolonged ectoparasite-controlling agent for animal

Publications (1)

Publication Number Publication Date
WO2019059412A1 true WO2019059412A1 (fr) 2019-03-28

Family

ID=63963354

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/JP2018/036162 WO2019059412A1 (fr) 2017-09-20 2018-09-19 Agent de lutte prolongée contre les ectoparasites pour un animal

Country Status (15)

Country Link
US (2) US11696913B2 (fr)
EP (1) EP3684181A1 (fr)
JP (2) JP7277445B2 (fr)
KR (1) KR102590088B1 (fr)
CN (2) CN111132549B (fr)
AU (1) AU2018335796A1 (fr)
BR (1) BR112020005628A2 (fr)
CA (1) CA3076539A1 (fr)
CL (1) CL2020000739A1 (fr)
IL (1) IL273416B2 (fr)
MX (1) MX2020002982A (fr)
RU (1) RU2770703C2 (fr)
TW (1) TWI786187B (fr)
UA (1) UA125914C2 (fr)
WO (1) WO2019059412A1 (fr)

Cited By (37)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2021013720A1 (fr) 2019-07-23 2021-01-28 Bayer Aktiengesellschaft Nouveaux composés hétéroaryle-triazole utilisés comme pesticides
WO2021013719A1 (fr) 2019-07-23 2021-01-28 Bayer Aktiengesellschaft Nouveaux composés hétéroaryle-triazole utilisés comme pesticides
WO2021013721A1 (fr) 2019-07-22 2021-01-28 Bayer Aktiengesellschaft Triazoles et pyrazoles à substitution 5-amino utilisés comme pesticides
CN112430210A (zh) * 2019-08-26 2021-03-02 沈阳化工大学 一种双酰胺类化合物及其应用
WO2021069567A1 (fr) 2019-10-09 2021-04-15 Bayer Aktiengesellschaft Nouveaux composés hétéroaryle-triazole utilisés comme pesticides
WO2021069569A1 (fr) 2019-10-09 2021-04-15 Bayer Aktiengesellschaft Nouveaux composés hétéroaryle-triazole en tant que pesticides
WO2021105091A1 (fr) 2019-11-25 2021-06-03 Bayer Aktiengesellschaft Nouveaux composés hétéroaryle-triazole en tant que pesticides
WO2021139370A1 (fr) * 2020-01-07 2021-07-15 沈阳化工大学 Composé amide et son application
CN113321595A (zh) * 2020-02-28 2021-08-31 南通泰禾化工股份有限公司 一种间二酰胺类化合物及其应用
US11180443B2 (en) * 2019-10-25 2021-11-23 Cac Nantong Chemical Co., Ltd Preparation method for m-diamide compounds
EP3929189A1 (fr) 2020-06-25 2021-12-29 Bayer Animal Health GmbH Nouveaux dérivés de pyrazine hétéroaryle substitués utilisés en tant que pesticides
WO2022002818A1 (fr) 2020-07-02 2022-01-06 Bayer Aktiengesellschaft Dérivés d'hétérocyclène utiles en tant qu'agents de lutte contre les nuisibles
WO2022033991A1 (fr) 2020-08-13 2022-02-17 Bayer Aktiengesellschaft Triazoles à substitution 5-amino utilisés en tant qu'agents de lutte contre les nuisibles
WO2022053453A1 (fr) 2020-09-09 2022-03-17 Bayer Aktiengesellschaft Azole carboxamide servant d'agents de lutte contre les nuisibles
EP3974414A1 (fr) 2020-09-25 2022-03-30 Bayer AG Pyrazoles et triazoles substitués par un 5-amino en tant que pesticides
WO2022101502A1 (fr) 2020-11-16 2022-05-19 Virbac Comprimé comprenant du modoflaner comme principe actif
EP4036083A1 (fr) 2021-02-02 2022-08-03 Bayer Aktiengesellschaft Hétéréocycles substitués de 5-oxy en tant que pesticides
DE102022105426A1 (de) 2021-03-10 2022-09-15 Jiangxi Tianyu Chemical Co., Ltd. Verfahren zur Herstellung von 4-(Heptafluor-2-propyl)-2-trifluormethylanilin und dessen Verwendung
WO2022207496A1 (fr) 2021-03-30 2022-10-06 Bayer Aktiengesellschaft 3-(hétéro)aryl-5-chlorodifluorométhyl-1,2,4-oxadiazole en tant que fongicide
WO2022207494A1 (fr) 2021-03-30 2022-10-06 Bayer Aktiengesellschaft 3-(hétéro)aryl-5-chlorodifluorométhyl-1,2,4-oxadiazole en tant que fongicide
WO2022233777A1 (fr) 2021-05-06 2022-11-10 Bayer Aktiengesellschaft Imidazoles annelés substitués par alkylamide et leur utilisation comme insecticides
WO2022238391A1 (fr) 2021-05-12 2022-11-17 Bayer Aktiengesellschaft Dérivés hétérocycliques condensés à substitution 2-(het)aryle utilisés comme agents de lutte antiparasitaire
WO2023017120A1 (fr) 2021-08-13 2023-02-16 Bayer Aktiengesellschaft Combinaisons de composés actifs et compositions fongicides comprenant celles-ci
WO2023025682A1 (fr) 2021-08-25 2023-03-02 Bayer Aktiengesellschaft Nouveaux composés de pyrazinyle-triazole utilisés comme pesticides
EP4144739A1 (fr) 2021-09-02 2023-03-08 Bayer Aktiengesellschaft Pyrazoles annelés en tant que produit pesticide
EP4026831A4 (fr) * 2019-09-06 2023-08-30 Shenyang Sinochem Agrochemicals R&D Co., Ltd. Dérivé d'acide pipérique et son application
WO2023203038A1 (fr) 2022-04-19 2023-10-26 Syngenta Crop Protection Ag Lutte contre les insectes, les acariens et les nématodes nuisibles
WO2023213626A1 (fr) 2022-05-03 2023-11-09 Bayer Aktiengesellschaft Utilisation de (5s)-3-[3-(3-chloro-2-fluorophénoxy)-6-méthylpyridazin-4-yl]-5-(2-chloro-4-méthylbenzyl)-5,6-dihydro-4h-1,2,4-oxadiazine pour lutter contre des micro-organismes indésirables
WO2023213670A1 (fr) 2022-05-03 2023-11-09 Bayer Aktiengesellschaft Formes cristallines de (5s)-3-[3-(3-chloro-2-fluorophénoxy)-6-méthylpyridazin-4-yl]-5-(2-chloro-4-méthylbenzyl)-5,6-dihydro-4h-1,2,4-oxadiazine
WO2023237444A1 (fr) 2022-06-06 2023-12-14 Bayer Aktiengesellschaft Formulations agrochimiques comprenant une forme cristalline a de 4-[(6-chloro-3-pyridylméthyl)(2,2-difluoroéthyl)amino]furan-2(5h)-one
EP4295688A1 (fr) 2022-09-28 2023-12-27 Bayer Aktiengesellschaft Combinaison de composés actifs
EP4295683A1 (fr) 2022-06-21 2023-12-27 Bayer Aktiengesellschaft Formulations agrochimiques comprenant une forme cristalline de 4-[(6-chloro-3-pyridylméthyl)(2,2-difluoroéthyl)amino]4-alkoxy(5h)-one
US11891371B2 (en) * 2017-06-29 2024-02-06 Shenyang Sinochem Agrochemicals R&D Co., LTD Piperonylic acid derivative and preparation and application thereof
WO2024068519A1 (fr) 2022-09-28 2024-04-04 Bayer Aktiengesellschaft 3-(hétéro)aryl-5-chlorodifluorométhyl-1,2,4-oxadiazole utilisé comme fongicide
WO2024068520A1 (fr) 2022-09-28 2024-04-04 Bayer Aktiengesellschaft 3-(hétéro)aryl-5-chlorodifluorométhyl-1,2,4-oxadiazole utilisé comme fongicide
WO2024068517A1 (fr) 2022-09-28 2024-04-04 Bayer Aktiengesellschaft 3-(hétéro)aryl-5-chlorodifluorométhyl-1,2,4-oxadiazole utilisé comme fongicide
WO2024068518A1 (fr) 2022-09-28 2024-04-04 Bayer Aktiengesellschaft 3-hétéroaryl-5-chlorodifluorométhyl-1,2,4-oxadiazole utilisé comme fongicide

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN112219852A (zh) * 2020-10-20 2021-01-15 青岛滕润翔检测评价有限公司 一种含烟酰胺类化合物的杀虫组合物在防治金银花虫害中的用途
CN113527109A (zh) * 2021-07-08 2021-10-22 南京先进生物材料与过程装备研究院有限公司 一种微流场反应技术制备全氟烷基苯胺的方法
CN115611767A (zh) * 2021-07-12 2023-01-17 沈阳化工大学 一种酰胺类化合物及其用途
CN114394912B (zh) * 2022-01-24 2024-01-26 海利尔药业集团股份有限公司 一种间二酰胺类化合物或其作为农药可接受的盐、组合物及其用途

Citations (36)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2003106457A1 (fr) 2002-06-14 2003-12-24 Syngenta Limited Derives de spiroindolinepiperidine
WO2004099160A1 (fr) 2003-05-12 2004-11-18 Sumitomo Chemical Company, Limited Composes de pyrimidine et compostion de lutte contre les animaux nuisibles contenant ces composes
WO2005073165A1 (fr) 2004-01-28 2005-08-11 Mitsui Chemicals, Inc. Dérivés amides, processus de fabrication et méthode d'application en tant qu'insecticide
WO2006003494A2 (fr) 2004-06-28 2006-01-12 Syngenta Participations Ag Composes chimiques
WO2006043635A1 (fr) 2004-10-20 2006-04-27 Kumiai Chemical Industry Co., Ltd. Dérivé de 3-triazolylphénylsulfide et insecticide/acaricide/nématicide incluant ledit dérivé au titre de principe actif
WO2007013150A1 (fr) 2005-07-27 2007-02-01 Mitsui Chemicals, Inc. Composition antiparasitaire
WO2007040282A1 (fr) 2005-10-06 2007-04-12 Nippon Soda Co., Ltd. Compose d'amine cyclique et agent pesticide
WO2008031534A1 (fr) * 2006-09-11 2008-03-20 Syngenta Participations Ag Composés insecticides
EP1916236A1 (fr) * 2005-06-23 2008-04-30 Mitsui Chemicals, Inc. Dérivé d amide, pesticide contenant ledit composé et utilisation correspondante
CN101337937A (zh) 2008-08-12 2009-01-07 国家农药创制工程技术研究中心 具有杀虫活性的n-苯基-3-取代氨基吡唑类化合物
CN101337940A (zh) 2008-08-12 2009-01-07 国家农药创制工程技术研究中心 具杀虫活性的含氮杂环二氯烯丙醚类化合物
WO2009080203A2 (fr) * 2007-12-21 2009-07-02 Bayer Cropscience Ag Dérivés d'aminobenzamide utiles en tant qu'agents pour lutter contre les parasites chez des animaux
JP2010018586A (ja) 2008-07-14 2010-01-28 Meiji Seika Kaisha Ltd Ｐｆ１３６４物質、その製造方法、生産菌株、及び、それを有効成分とする農園芸用殺虫剤
WO2010013567A1 (fr) 2008-08-01 2010-02-04 三井化学アグロ株式会社 Dérivé d'amide, agent de lutte contre les nuisibles contenant le dérivé d'amide et procédé de lutte contre les organismes nuisibles
WO2010018714A1 (fr) 2008-08-13 2010-02-18 三井化学アグロ株式会社 Dérivé amide, agent antiparasitaire contenant le dérivé amide et utilisation de l’agent antiparasitaire
WO2010018857A1 (fr) 2008-08-13 2010-02-18 三井化学アグロ株式会社 Procédé de production d’un dérivé amide
WO2010051926A2 (fr) 2008-11-05 2010-05-14 Bayer Cropscience Aktiengesellschaft Nouveaux composés substitués par halogène
WO2010052161A2 (fr) 2008-11-06 2010-05-14 Syngenta Participations Ag Compositions herbicides
CN101715774A (zh) 2008-10-09 2010-06-02 浙江化工科技集团有限公司 一个具有杀虫活性化合物制备及用途
WO2011085575A1 (fr) 2010-01-15 2011-07-21 江苏省农药研究所股份有限公司 Composés de formanilide hétérocyclique, leurs procédés de synthèse et leur utilisation
WO2011093415A1 (fr) 2010-01-29 2011-08-04 三井化学アグロ株式会社 Composition et procédé de lutte contre les parasites des animaux
WO2012029672A1 (fr) 2010-08-31 2012-03-08 Ｍｅｉｊｉ Ｓｅｉｋａファルマ株式会社 Agent de lutte contre des organismes nuisibles
WO2012034403A1 (fr) 2010-09-14 2012-03-22 中化蓝天集团有限公司 Composés de fluorométhoxypyrazole et d'anthranilamide, leurs procédés de synthèse et leurs utilisations
CN102391261A (zh) 2011-10-14 2012-03-28 上海交通大学 一种n-取代噁二嗪类化合物及其制备方法和应用
WO2013050317A1 (fr) 2011-10-03 2013-04-11 Syngenta Limited Formes polymorphes d'un dérivé d'isoxazoline
CN103109816A (zh) 2013-01-25 2013-05-22 青岛科技大学 硫代苯甲酰胺类化合物及其应用
CN103232431A (zh) 2013-01-25 2013-08-07 青岛科技大学 一种二卤代吡唑酰胺类化合物及其应用
WO2013144213A1 (fr) 2012-03-30 2013-10-03 Basf Se Composés de pyridylidène n-substitués et dérivés destinés à lutter contre les animaux nuisibles
EP2647626A1 (fr) 2012-04-03 2013-10-09 Syngenta Participations AG. Dérivés de 1-aza-spiro[4.5]déc-3-ène and 1,8-diaza-spiro[4.5]déc-3-ène en tant que pesticides
WO2013162715A2 (fr) 2012-04-27 2013-10-31 Dow Agrosciences Llc Compositions pesticides et procédés correspondants
CN103524422A (zh) 2013-10-11 2014-01-22 中国农业科学院植物保护研究所 苯并咪唑衍生物及其制备方法和用途
US20140213448A1 (en) 2012-04-27 2014-07-31 Dow Agrosciences Llc Pesticidal compositions and processes related thereto
US20140275503A1 (en) 2013-03-13 2014-09-18 Dow Agrosciences Llc Process for the preparation of certain triaryl rhamnose carbamates
WO2015058021A1 (fr) 2013-10-17 2015-04-23 Dow Agrosciences Llc Procédés de préparation de de composés pesticides
WO2015058028A1 (fr) 2013-10-17 2015-04-23 Dow Agrosciences Llc Procédés de préparation de composés pesticides
WO2015097094A1 (fr) * 2013-12-23 2015-07-02 Syngenta Participations Ag Composés insecticides

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU778580B2 (en) * 2000-11-09 2004-12-09 Sumitomo Chemical Company, Limited Ectoparasite control compositions
JP4222293B2 (ja) 2004-11-15 2009-02-12 トヨタ自動車株式会社 車両用駆動装置の制御装置
CN101203485A (zh) * 2005-06-23 2008-06-18 三井化学株式会社 酰胺衍生物、含有该化合物的杀虫剂及其使用方法
JP5207530B2 (ja) 2008-07-10 2013-06-12 大日精化工業株式会社 プラスチック用塗料
US8686044B2 (en) * 2008-08-13 2014-04-01 Mitsui Chemicals Agro, Inc. Amide derivative, pest control agent containing the amide derivative, and use of the amide derivative
JP5246437B2 (ja) 2009-10-29 2013-07-24 株式会社エクォス・リサーチ 車両用キャンバ角制御装置
US20140343049A1 (en) * 2011-08-22 2014-11-20 Syngenta Participations Ag Dihydrofuran derivatives as insecticidal compounds
WO2014159335A1 (fr) * 2013-03-12 2014-10-02 Dow Agrosciences Llc Compositions herbicides comprenant l'acide 4-amino-3-chloro-5-fluoro-6-(4-chloro-2-fluoro-3-méthoxyphényl) pyridine-2-carboxylique
CN105189457A (zh) * 2013-04-02 2015-12-23 先正达参股股份有限公司 杀虫化合物
BR112016014774B1 (pt) * 2013-12-23 2021-08-10 Syngenta Participations Ag Compostos inseticidas
CN108368030B (zh) * 2015-12-18 2020-09-18 三井化学Agro株式会社 芳香族酰胺衍生物的制造方法

Patent Citations (39)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2003106457A1 (fr) 2002-06-14 2003-12-24 Syngenta Limited Derives de spiroindolinepiperidine
WO2004099160A1 (fr) 2003-05-12 2004-11-18 Sumitomo Chemical Company, Limited Composes de pyrimidine et compostion de lutte contre les animaux nuisibles contenant ces composes
WO2005073165A1 (fr) 2004-01-28 2005-08-11 Mitsui Chemicals, Inc. Dérivés amides, processus de fabrication et méthode d'application en tant qu'insecticide
WO2006003494A2 (fr) 2004-06-28 2006-01-12 Syngenta Participations Ag Composes chimiques
WO2006043635A1 (fr) 2004-10-20 2006-04-27 Kumiai Chemical Industry Co., Ltd. Dérivé de 3-triazolylphénylsulfide et insecticide/acaricide/nématicide incluant ledit dérivé au titre de principe actif
EP1916236A1 (fr) * 2005-06-23 2008-04-30 Mitsui Chemicals, Inc. Dérivé d amide, pesticide contenant ledit composé et utilisation correspondante
WO2007013150A1 (fr) 2005-07-27 2007-02-01 Mitsui Chemicals, Inc. Composition antiparasitaire
WO2007040282A1 (fr) 2005-10-06 2007-04-12 Nippon Soda Co., Ltd. Compose d'amine cyclique et agent pesticide
WO2007040280A1 (fr) 2005-10-06 2007-04-12 Nippon Soda Co., Ltd. Cyclic amine compound and pest control agent
WO2008031534A1 (fr) * 2006-09-11 2008-03-20 Syngenta Participations Ag Composés insecticides
WO2009080203A2 (fr) * 2007-12-21 2009-07-02 Bayer Cropscience Ag Dérivés d'aminobenzamide utiles en tant qu'agents pour lutter contre les parasites chez des animaux
JP2010018586A (ja) 2008-07-14 2010-01-28 Meiji Seika Kaisha Ltd Ｐｆ１３６４物質、その製造方法、生産菌株、及び、それを有効成分とする農園芸用殺虫剤
WO2010013567A1 (fr) 2008-08-01 2010-02-04 三井化学アグロ株式会社 Dérivé d'amide, agent de lutte contre les nuisibles contenant le dérivé d'amide et procédé de lutte contre les organismes nuisibles
CN101337937A (zh) 2008-08-12 2009-01-07 国家农药创制工程技术研究中心 具有杀虫活性的n-苯基-3-取代氨基吡唑类化合物
CN101337940A (zh) 2008-08-12 2009-01-07 国家农药创制工程技术研究中心 具杀虫活性的含氮杂环二氯烯丙醚类化合物
WO2010018714A1 (fr) 2008-08-13 2010-02-18 三井化学アグロ株式会社 Dérivé amide, agent antiparasitaire contenant le dérivé amide et utilisation de l’agent antiparasitaire
WO2010018857A1 (fr) 2008-08-13 2010-02-18 三井化学アグロ株式会社 Procédé de production d’un dérivé amide
CN101715774A (zh) 2008-10-09 2010-06-02 浙江化工科技集团有限公司 一个具有杀虫活性化合物制备及用途
WO2010051926A2 (fr) 2008-11-05 2010-05-14 Bayer Cropscience Aktiengesellschaft Nouveaux composés substitués par halogène
WO2010052161A2 (fr) 2008-11-06 2010-05-14 Syngenta Participations Ag Compositions herbicides
WO2011085575A1 (fr) 2010-01-15 2011-07-21 江苏省农药研究所股份有限公司 Composés de formanilide hétérocyclique, leurs procédés de synthèse et leur utilisation
WO2011093415A1 (fr) 2010-01-29 2011-08-04 三井化学アグロ株式会社 Composition et procédé de lutte contre les parasites des animaux
EP2529620A1 (fr) * 2010-01-29 2012-12-05 Mitsui Chemicals Agro, Inc. Composition et procédé de lutte contre les parasites des animaux
WO2012029672A1 (fr) 2010-08-31 2012-03-08 Ｍｅｉｊｉ Ｓｅｉｋａファルマ株式会社 Agent de lutte contre des organismes nuisibles
WO2012034403A1 (fr) 2010-09-14 2012-03-22 中化蓝天集团有限公司 Composés de fluorométhoxypyrazole et d'anthranilamide, leurs procédés de synthèse et leurs utilisations
WO2013050317A1 (fr) 2011-10-03 2013-04-11 Syngenta Limited Formes polymorphes d'un dérivé d'isoxazoline
CN102391261A (zh) 2011-10-14 2012-03-28 上海交通大学 一种n-取代噁二嗪类化合物及其制备方法和应用
WO2013144213A1 (fr) 2012-03-30 2013-10-03 Basf Se Composés de pyridylidène n-substitués et dérivés destinés à lutter contre les animaux nuisibles
EP2647626A1 (fr) 2012-04-03 2013-10-09 Syngenta Participations AG. Dérivés de 1-aza-spiro[4.5]déc-3-ène and 1,8-diaza-spiro[4.5]déc-3-ène en tant que pesticides
WO2013162716A2 (fr) 2012-04-27 2013-10-31 Dow Agrosciences Llc Compositions pesticides et procédés correspondants
WO2013162715A2 (fr) 2012-04-27 2013-10-31 Dow Agrosciences Llc Compositions pesticides et procédés correspondants
US20140213448A1 (en) 2012-04-27 2014-07-31 Dow Agrosciences Llc Pesticidal compositions and processes related thereto
CN103232431A (zh) 2013-01-25 2013-08-07 青岛科技大学 一种二卤代吡唑酰胺类化合物及其应用
CN103109816A (zh) 2013-01-25 2013-05-22 青岛科技大学 硫代苯甲酰胺类化合物及其应用
US20140275503A1 (en) 2013-03-13 2014-09-18 Dow Agrosciences Llc Process for the preparation of certain triaryl rhamnose carbamates
CN103524422A (zh) 2013-10-11 2014-01-22 中国农业科学院植物保护研究所 苯并咪唑衍生物及其制备方法和用途
WO2015058021A1 (fr) 2013-10-17 2015-04-23 Dow Agrosciences Llc Procédés de préparation de de composés pesticides
WO2015058028A1 (fr) 2013-10-17 2015-04-23 Dow Agrosciences Llc Procédés de préparation de composés pesticides
WO2015097094A1 (fr) * 2013-12-23 2015-07-02 Syngenta Participations Ag Composés insecticides

Non-Patent Citations (27)

* Cited by examiner, † Cited by third party
Title
"Pesticide Manual (''The Pesticide Manual", 2012, BRITISH CROP PROTECTION COUNCIL
CHEMICAL ABSTRACTS, Columbus, Ohio, US; abstract no. 1105672-77-2
CHEMICAL ABSTRACTS, Columbus, Ohio, US; abstract no. 1108184-52-6
CHEMICAL ABSTRACTS, Columbus, Ohio, US; abstract no. 1181213-14-8
CHEMICAL ABSTRACTS, Columbus, Ohio, US; abstract no. 1204776-60-2
CHEMICAL ABSTRACTS, Columbus, Ohio, US; abstract no. 1225292-17-0
CHEMICAL ABSTRACTS, Columbus, Ohio, US; abstract no. 1226889-14-0
CHEMICAL ABSTRACTS, Columbus, Ohio, US; abstract no. 1232543-85-9
CHEMICAL ABSTRACTS, Columbus, Ohio, US; abstract no. 1233882-22-8
CHEMICAL ABSTRACTS, Columbus, Ohio, US; abstract no. 1253850-56-4
CHEMICAL ABSTRACTS, Columbus, Ohio, US; abstract no. 1268277-22-0
CHEMICAL ABSTRACTS, Columbus, Ohio, US; abstract no. 1332628-83-7
CHEMICAL ABSTRACTS, Columbus, Ohio, US; abstract no. 1363400-41-2
CHEMICAL ABSTRACTS, Columbus, Ohio, US; abstract no. 1370358-69-2
CHEMICAL ABSTRACTS, Columbus, Ohio, US; abstract no. 1440516-42-6
CHEMICAL ABSTRACTS, Columbus, Ohio, US; abstract no. 1449220-44-3
CHEMICAL ABSTRACTS, Columbus, Ohio, US; abstract no. 1461743-15-6
CHEMICAL ABSTRACTS, Columbus, Ohio, US; abstract no. 1477919-27-9
CHEMICAL ABSTRACTS, Columbus, Ohio, US; abstract no. 1477923-37-7
CHEMICAL ABSTRACTS, Columbus, Ohio, US; abstract no. 1542271-46-4
CHEMICAL ABSTRACTS, Columbus, Ohio, US; abstract no. 637360-23-7
CHEMICAL ABSTRACTS, Columbus, Ohio, US; abstract no. 792914-58-0
CHEMICAL ABSTRACTS, Columbus, Ohio, US; abstract no. 872999-66-1
CHEMICAL ABSTRACTS, Columbus, Ohio, US; abstract no. 885026-50-6
CHEMICAL ABSTRACTS, Columbus, Ohio, US; abstract no. 933798-27-7
CHEMICAL ABSTRACTS, Columbus, Ohio, US; abstract no. 934001-66-8
MEHLHOM ET AL.: "Encyclopaedic Reference of Parasitology"

Cited By (47)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US11891371B2 (en) * 2017-06-29 2024-02-06 Shenyang Sinochem Agrochemicals R&D Co., LTD Piperonylic acid derivative and preparation and application thereof
WO2021013721A1 (fr) 2019-07-22 2021-01-28 Bayer Aktiengesellschaft Triazoles et pyrazoles à substitution 5-amino utilisés comme pesticides
WO2021013719A1 (fr) 2019-07-23 2021-01-28 Bayer Aktiengesellschaft Nouveaux composés hétéroaryle-triazole utilisés comme pesticides
WO2021013720A1 (fr) 2019-07-23 2021-01-28 Bayer Aktiengesellschaft Nouveaux composés hétéroaryle-triazole utilisés comme pesticides
CN112430211A (zh) * 2019-08-26 2021-03-02 沈阳化工大学 一种间苯二甲酰胺类化合物及其应用
WO2021036965A1 (fr) * 2019-08-26 2021-03-04 沈阳化工大学 Composé d'isophtalamide et son utilisation
WO2021036966A1 (fr) * 2019-08-26 2021-03-04 沈阳化工大学 Composé bisamide et son application
CN114555559A (zh) * 2019-08-26 2022-05-27 广西思钺生物科技有限责任公司 一种间苯二甲酰胺类化合物及其应用
CN115038691B (zh) * 2019-08-26 2023-10-27 广西思钺生物科技有限责任公司 一种双酰胺类化合物及其应用
CN112430210A (zh) * 2019-08-26 2021-03-02 沈阳化工大学 一种双酰胺类化合物及其应用
CN115038691A (zh) * 2019-08-26 2022-09-09 广西思钺生物科技有限责任公司 一种双酰胺类化合物及其应用
EP4026831A4 (fr) * 2019-09-06 2023-08-30 Shenyang Sinochem Agrochemicals R&D Co., Ltd. Dérivé d'acide pipérique et son application
WO2021069567A1 (fr) 2019-10-09 2021-04-15 Bayer Aktiengesellschaft Nouveaux composés hétéroaryle-triazole utilisés comme pesticides
WO2021069569A1 (fr) 2019-10-09 2021-04-15 Bayer Aktiengesellschaft Nouveaux composés hétéroaryle-triazole en tant que pesticides
US11180443B2 (en) * 2019-10-25 2021-11-23 Cac Nantong Chemical Co., Ltd Preparation method for m-diamide compounds
WO2021105091A1 (fr) 2019-11-25 2021-06-03 Bayer Aktiengesellschaft Nouveaux composés hétéroaryle-triazole en tant que pesticides
CN113149900B (zh) * 2020-01-07 2023-09-15 沈阳化工大学 一种酰胺类化合物及其应用
WO2021139370A1 (fr) * 2020-01-07 2021-07-15 沈阳化工大学 Composé amide et son application
CN113149900A (zh) * 2020-01-07 2021-07-23 沈阳化工大学 一种酰胺类化合物及其应用
CN113321595B (zh) * 2020-02-28 2023-12-22 南通泰禾化工股份有限公司 一种间二酰胺类化合物及其应用
CN113321595A (zh) * 2020-02-28 2021-08-31 南通泰禾化工股份有限公司 一种间二酰胺类化合物及其应用
WO2021259997A1 (fr) 2020-06-25 2021-12-30 Bayer Animal Health Gmbh Nouveaux dérivés de pyrazine substitués par hétéroaryle utilisés en tant que pesticides
EP3929189A1 (fr) 2020-06-25 2021-12-29 Bayer Animal Health GmbH Nouveaux dérivés de pyrazine hétéroaryle substitués utilisés en tant que pesticides
WO2022002818A1 (fr) 2020-07-02 2022-01-06 Bayer Aktiengesellschaft Dérivés d'hétérocyclène utiles en tant qu'agents de lutte contre les nuisibles
WO2022033991A1 (fr) 2020-08-13 2022-02-17 Bayer Aktiengesellschaft Triazoles à substitution 5-amino utilisés en tant qu'agents de lutte contre les nuisibles
WO2022053453A1 (fr) 2020-09-09 2022-03-17 Bayer Aktiengesellschaft Azole carboxamide servant d'agents de lutte contre les nuisibles
EP3974414A1 (fr) 2020-09-25 2022-03-30 Bayer AG Pyrazoles et triazoles substitués par un 5-amino en tant que pesticides
WO2022101502A1 (fr) 2020-11-16 2022-05-19 Virbac Comprimé comprenant du modoflaner comme principe actif
EP4036083A1 (fr) 2021-02-02 2022-08-03 Bayer Aktiengesellschaft Hétéréocycles substitués de 5-oxy en tant que pesticides
DE102022105426A1 (de) 2021-03-10 2022-09-15 Jiangxi Tianyu Chemical Co., Ltd. Verfahren zur Herstellung von 4-(Heptafluor-2-propyl)-2-trifluormethylanilin und dessen Verwendung
WO2022207496A1 (fr) 2021-03-30 2022-10-06 Bayer Aktiengesellschaft 3-(hétéro)aryl-5-chlorodifluorométhyl-1,2,4-oxadiazole en tant que fongicide
WO2022207494A1 (fr) 2021-03-30 2022-10-06 Bayer Aktiengesellschaft 3-(hétéro)aryl-5-chlorodifluorométhyl-1,2,4-oxadiazole en tant que fongicide
WO2022233777A1 (fr) 2021-05-06 2022-11-10 Bayer Aktiengesellschaft Imidazoles annelés substitués par alkylamide et leur utilisation comme insecticides
WO2022238391A1 (fr) 2021-05-12 2022-11-17 Bayer Aktiengesellschaft Dérivés hétérocycliques condensés à substitution 2-(het)aryle utilisés comme agents de lutte antiparasitaire
WO2023017120A1 (fr) 2021-08-13 2023-02-16 Bayer Aktiengesellschaft Combinaisons de composés actifs et compositions fongicides comprenant celles-ci
WO2023025682A1 (fr) 2021-08-25 2023-03-02 Bayer Aktiengesellschaft Nouveaux composés de pyrazinyle-triazole utilisés comme pesticides
EP4144739A1 (fr) 2021-09-02 2023-03-08 Bayer Aktiengesellschaft Pyrazoles annelés en tant que produit pesticide
WO2023203038A1 (fr) 2022-04-19 2023-10-26 Syngenta Crop Protection Ag Lutte contre les insectes, les acariens et les nématodes nuisibles
WO2023213670A1 (fr) 2022-05-03 2023-11-09 Bayer Aktiengesellschaft Formes cristallines de (5s)-3-[3-(3-chloro-2-fluorophénoxy)-6-méthylpyridazin-4-yl]-5-(2-chloro-4-méthylbenzyl)-5,6-dihydro-4h-1,2,4-oxadiazine
WO2023213626A1 (fr) 2022-05-03 2023-11-09 Bayer Aktiengesellschaft Utilisation de (5s)-3-[3-(3-chloro-2-fluorophénoxy)-6-méthylpyridazin-4-yl]-5-(2-chloro-4-méthylbenzyl)-5,6-dihydro-4h-1,2,4-oxadiazine pour lutter contre des micro-organismes indésirables
WO2023237444A1 (fr) 2022-06-06 2023-12-14 Bayer Aktiengesellschaft Formulations agrochimiques comprenant une forme cristalline a de 4-[(6-chloro-3-pyridylméthyl)(2,2-difluoroéthyl)amino]furan-2(5h)-one
EP4295683A1 (fr) 2022-06-21 2023-12-27 Bayer Aktiengesellschaft Formulations agrochimiques comprenant une forme cristalline de 4-[(6-chloro-3-pyridylméthyl)(2,2-difluoroéthyl)amino]4-alkoxy(5h)-one
EP4295688A1 (fr) 2022-09-28 2023-12-27 Bayer Aktiengesellschaft Combinaison de composés actifs
WO2024068519A1 (fr) 2022-09-28 2024-04-04 Bayer Aktiengesellschaft 3-(hétéro)aryl-5-chlorodifluorométhyl-1,2,4-oxadiazole utilisé comme fongicide
WO2024068520A1 (fr) 2022-09-28 2024-04-04 Bayer Aktiengesellschaft 3-(hétéro)aryl-5-chlorodifluorométhyl-1,2,4-oxadiazole utilisé comme fongicide
WO2024068517A1 (fr) 2022-09-28 2024-04-04 Bayer Aktiengesellschaft 3-(hétéro)aryl-5-chlorodifluorométhyl-1,2,4-oxadiazole utilisé comme fongicide
WO2024068518A1 (fr) 2022-09-28 2024-04-04 Bayer Aktiengesellschaft 3-hétéroaryl-5-chlorodifluorométhyl-1,2,4-oxadiazole utilisé comme fongicide

Also Published As

Publication number Publication date
UA125914C2 (uk) 2022-07-06
BR112020005628A2 (pt) 2020-10-13
CN111132549A (zh) 2020-05-08
CA3076539A1 (fr) 2019-03-28
US20230226037A1 (en) 2023-07-20
US20200281914A1 (en) 2020-09-10
CN114591232A (zh) 2022-06-07
RU2020113549A (ru) 2021-10-20
JP2020534334A (ja) 2020-11-26
JP7277445B2 (ja) 2023-05-19
IL273416A (en) 2020-05-31
AU2018335796A1 (en) 2020-05-07
US11696913B2 (en) 2023-07-11
MX2020002982A (es) 2020-07-22
TWI786187B (zh) 2022-12-11
CN111132549B (zh) 2022-04-12
EP3684181A1 (fr) 2020-07-29
KR20200055761A (ko) 2020-05-21
IL273416B2 (en) 2023-06-01
RU2770703C2 (ru) 2022-04-21
JP2023052979A (ja) 2023-04-12
TW201920080A (zh) 2019-06-01
RU2020113549A3 (fr) 2021-10-26
KR102590088B1 (ko) 2023-10-17
CL2020000739A1 (es) 2020-10-02

Similar Documents

Publication Publication Date Title
US11696913B2 (en) Prolonged ectoparasite-controlling agent for animal
WO2016174049A1 (fr) Combinaisons anti-parasitaires comprenant des composés à substitution halogène
EP3181552B1 (fr) Composé de diarylimidazole et agent de lutte antiparasitaire
CN112771034B (zh) 杂芳基唑化合物及有害生物防除剂
ES2708678T3 (es) Compuesto de ariloxiurea y agente de control de plagas
CA2863384C (fr) Compose aryloxyacetamide et pesticide associe
JP6450762B2 (ja) 殺有害生物活性を有する化合物
AU2015340755A1 (en) Compounds for use in anthelminthic treatment
WO2023127806A1 (fr) Agent de lutte contre les organismes nuisibles comprenant un dérivé d&#39;aryletétrahydropyridine ou des sels de celui-ci et un composé de celui-ci, et procédé de mise en œuvre de cet agent
JP2013241352A (ja) 有害生物防除剤組成物および有害生物防除方法
EP3113614A1 (fr) Combinaisons insecticides synergiques contenant du pyrazole-5-carboxamide et un autre insecticide
WO2023171665A1 (fr) Dérivé de pipéridinone ou sel de celui-ci, agent de lutte contre les organismes nuisibles contenant ledit composé et procédé d&#39;utilisation associé
WO2024005032A1 (fr) Dérivé d&#39;azépandione ou sel de celui-ci, agent de lutte contre les organismes nuisibles contenant ledit composé et procédé d&#39;utilisation associé
WO2023127808A1 (fr) Agent de lutte contre les organismes nuisibles comprenant un dérivé d&#39;arylecyclohexanedione ou des sels de celui-ci et un composé de celui-ci, et procédé de mise en œuvre de cet agent
JP2021080246A (ja) ジヒドロイソキサゾール化合物及び有害生物防除剤
WO2023127809A1 (fr) Agent de lutte contre les organismes nuisibles comprenant un dérivé d&#39;aryledihydropyranne ou des sels de celui-ci et un composé de celui-ci, et procédé de mise en œuvre de cet agent
WO2013164954A1 (fr) Composé de pipéridine et son utilisation pour la lutte contre des organismes nuisibles
JP2013216626A (ja) アリールオキシ酢酸アミド化合物を含有する殺ダニ剤または殺虫剤

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 18792551

Country of ref document: EP

Kind code of ref document: A1

ENP Entry into the national phase

Ref document number: 3076539

Country of ref document: CA

Ref document number: 2020516756

Country of ref document: JP

Kind code of ref document: A

NENP Non-entry into the national phase

Ref country code: DE

ENP Entry into the national phase

Ref document number: 20207011091

Country of ref document: KR

Kind code of ref document: A

ENP Entry into the national phase

Ref document number: 2018792551

Country of ref document: EP

Effective date: 20200420

ENP Entry into the national phase

Ref document number: 2018335796

Country of ref document: AU

Date of ref document: 20180919

Kind code of ref document: A

REG Reference to national code

Ref country code: BR

Ref legal event code: B01A

Ref document number: 112020005628

Country of ref document: BR

ENP Entry into the national phase

Ref document number: 112020005628

Country of ref document: BR

Kind code of ref document: A2

Effective date: 20200320